| SIB Home page | Computational Cancer Genomics | Swiss EMBnet node | ExPASy | ISREC |
| CleanEx Tutorial |
Select the first dataset by clicking in the corresponding button.
Once in the selected dataset's form, select the two experiments pools that you want to compare and submit your job. On the result page, you will have two choices. You can either :
| Organism | PLatform Type | Dataset | Description of experiment | Medline | Documentation file |
|---|---|---|---|---|---|
| Human 642 | AFFY 479 | A0001 | Oligonucleotide array data for tumor and normal colon tissues | 10359783 | A0001_DOC |
| AFFY004 | Molecular Classification of Human Carcinomas | 11606367 | AFFY004_DOC | ||
| GSE1000 | Osteosarcoma TE85 cell tissue culture study | GSE1000_DOC | |||
| GSE1004 | Molecular profiles (HG-U95A) of dystrophin-deficient and normal human muscle | 12415109 | GSE1004_DOC | ||
| GSE10072 | Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival | GSE10072_DOC | |||
| GSE1007A | Molecular profiles(HG-U95B,C,D,E) of dystrophin-deficient and normal human skeletal muscle | 12698323 | GSE1007A_DOC | ||
| GSE1007B | Molecular profiles(HG-U95B,C,D,E) of dystrophin-deficient and normal human skeletal muscle | 12698323 | GSE1007B_DOC | ||
| GSE1007C | Molecular profiles(HG-U95B,C,D,E) of dystrophin-deficient and normal human skeletal muscle | 12698323 | GSE1007C_DOC | ||
| GSE1007D | Molecular profiles(HG-U95B,C,D,E) of dystrophin-deficient and normal human skeletal muscle | 12698323 | GSE1007D_DOC | ||
| GSE1009 | Diabetic nephropathy | 15042541 | GSE1009_DOC | ||
| GSE1010 | FCHL study | GSE1010_DOC | |||
| GSE1017 | Acute Quadriplegic Myopathy | GSE1017_DOC | |||
| GSE1036 | Hemin timecourse 0-72h | 15252187 | GSE1036_DOC | ||
| GSE1045 | Estradiol Treated Breast Cancer Cells Expressing Mutant Estrogen Receptors | 15023342 | GSE1045_DOC | ||
| GSE1056 | Hypoxia and Hypoxia mimics | 15942021 | GSE1056_DOC | ||
| GSE1059 | Myometrial cells expressing CREB, CREM alpha, CREM tau2alpha, ATF2 or the ATF2-small gene | 15691874 | GSE1059_DOC | ||
| GSE1081 | Effect of a 4 hour treatment of 100 nM endothelin-1 on human primary lung fibroblasts | 15044479 | GSE1081_DOC | ||
| GSE1122 | Emphysema Lung Tissue Gene Expression Profiling | 15284076 | GSE1122_DOC | ||
| GSE1124 | Comparison between uncomplicated and severe malaria and between both and health | GSE1124_DOC | |||
| GSE1132A | IFN-Gamma keratinocytes | 15145801 | GSE1132A_DOC | ||
| GSE1132B | IFN-Gamma keratinocytes | 15145801 | GSE1132B_DOC | ||
| GSE1133A | tissue-specific pattern of mRNA expression | 15075390 | GSE1133A_DOC | ||
| GSE1140 | PMBCs and the effect of exercise | 15194674 | GSE1140_DOC | ||
| GSE1141 | Inflammatory bowel disease (HG-U133A) | GSE1141_DOC | |||
| GSE1142 | Inflammatory bowel disease (HG-U133B) | GSE1142_DOC | |||
| GSE1144 | aging of cultured human myotubes | GSE1144_DOC | |||
| GSE1145A | changes in cardiac transcription profiles brought about by heart failure | GSE1145A_DOC | |||
| GSE1145B | changes in cardiac transcription profiles brought about by heart failure | GSE1145B_DOC | |||
| GSE1147 | Sex Specific Transciption in Human Hypothalamus | GSE1147_DOC | |||
| GSE1152A | Inflammatory bowel disease | GSE1152A_DOC | |||
| GSE1152B | Inflammatory bowel disease | GSE1152B_DOC | |||
| GSE1153 | Estrogen-regulated gene expression in human osteosarcoma cells stably transfected with estrogen receptor alpha or beta | 15033914 | GSE1153_DOC | ||
| GSE1158 | Wilms tumor versus Stratagene Universal Reference | GSE1158_DOC | |||
| GSE1159 | Expression profiles of acute myeloid leukemia patient samples | 15084694 | GSE1159_DOC | ||
| GSE121A | Type 2 diabetes and insulin resistance | 12436343 | GSE121A_DOC | ||
| GSE121B | Type 2 diabetes and insulin resistance | 12436343 | GSE121B_DOC | ||
| GSE121C | Type 2 diabetes and insulin resistance | 12436343 | GSE121C_DOC | ||
| GSE121D | Type 2 diabetes and insulin resistance | 12436343 | GSE121D_DOC | ||
| GSE121E | Type 2 diabetes and insulin resistance | 12436343 | GSE121E_DOC | ||
| GSE1264 | Sindbis survivors | GSE1264_DOC | |||
| GSE1277 | HGPC, in monolayer, 0.5 vs. 20% serum | 15094393 | GSE1277_DOC | ||
| GSE1278 | HGPC, in monolayer, 0.5% serum | 15094393 | GSE1278_DOC | ||
| GSE1295A | STRRIDE Study | 15347626 | GSE1295A_DOC | ||
| GSE1295B | STRRIDE Study | 15347626 | GSE1295B_DOC | ||
| GSE1296 | Simple ambient preservation of human tissues for RNA expression array analysis | 15537428 | GSE1296_DOC | ||
| GSE1297 | Incipient Alzheimer's Disease: Microarray Correlation Analyses | 14769913 | GSE1297_DOC | ||
| GSE1299A | Breast Cancer Cell Line Experiment | 15161944 | GSE1299A_DOC | ||
| GSE1299B | Breast Cancer Cell Line Experiment | 15161944 | GSE1299B_DOC | ||
| GSE1299C | Breast Cancer Cell Line Experiment | 15161944 | GSE1299C_DOC | ||
| GSE1300 | Hereditary Spastic Paraparesis | GSE1300_DOC | |||
| GSE1302A | primary trophoblast study | 15161964 | GSE1302A_DOC | ||
| GSE1302B | primary trophoblast study | 15161964 | GSE1302B_DOC | ||
| GSE1302C | primary trophoblast study | 15161964 | GSE1302C_DOC | ||
| GSE1302D | primary trophoblast study | 15161964 | GSE1302D_DOC | ||
| GSE1302E | primary trophoblast study | 15161964 | GSE1302E_DOC | ||
| GSE1309 | Gene expession profiles for monoclonal cell lines with high or low levels of store-operated Ca2+ entry. | 15623568 | GSE1309_DOC | ||
| GSE1317 | Ultraviolet induced gene expression in human basal cell culture | GSE1317_DOC | |||
| GSE1318A | Myb specificity determinants | 15105423 | GSE1318A_DOC | ||
| GSE1318B | Myb specificity determinants | 15105423 | GSE1318B_DOC | ||
| GSE1323 | Isogenic primary tumor/metastasis comparison | 16531451 | GSE1323_DOC | ||
| GSE1343 | Burn/Trauma Study | 15548831 | GSE1343_DOC | ||
| GSE1347 | Pre-analytical changes of mRNA Gene Expression as the result from prolonged storage | 15238145 | GSE1347_DOC | ||
| GSE1364 | Long-Term Storage of Human Cells at Ambient Temperature | 16155929 | GSE1364_DOC | ||
| GSE1377 | Kaposi's sarcoma-associated herpes virus | 15220917 | GSE1377_DOC | ||
| GSE1397 | Trisomy 21 and TS13 | 16420667 | GSE1397_DOC | ||
| GSE1400 | MCF-7 Fractionated RNA | 15574777 | GSE1400_DOC | ||
| GSE1402 | Juvenile Rheumatoid Arthritis Profiles In PBMC and SFMC | 15150433 | GSE1402_DOC | ||
| GSE1403 | Cyclosporine A timecourse 0, 12, 48 hours | 16049326 | GSE1403_DOC | ||
| GSE1407 | HIV-based vector infected cells | 15314653 | GSE1407_DOC | ||
| GSE1410 | ASLV vector infected 293t-TVA cells | GSE1410_DOC | |||
| GSE1417 | Untreated vs. Camptothecin Treated HeLa cells | 15026349 | GSE1417_DOC | ||
| GSE1418 | Imatinib effects on CD34+ cells | 15618956 | GSE1418_DOC | ||
| GSE1420 | Barrett's esophagus, Barrett's-associated adenocarcinomas and normal esophageal epithelium | 15833844 | GSE1420_DOC | ||
| GSE1427A | Expression profiles in Blast Bank samples with AML/RAEB | GSE1427A_DOC | |||
| GSE1427B | Expression profiles in Blast Bank samples with AML/RAEB | GSE1427B_DOC | |||
| GSE1428 | Skeletal muscle sarcopenia | 15687482 | GSE1428_DOC | ||
| GSE1431 | Human prostate cancer tissues analyses | GSE1431_DOC | |||
| GSE1432 | Transcriptional Response of Human Microglial Cells to Interferon-gamma | 16163375 | GSE1432_DOC | ||
| GSE1455 | Two week Storage and Rehydration of HEK 293 Cells at Ambient Temperature | 16155929 | GSE1455_DOC | ||
| GSE1456A | Gene expression of breast cancer tissue in a large population-based cohort of Swedish patients | 16280042 | GSE1456A_DOC | ||
| GSE1456B | Gene expression of breast cancer tissue in a large population-based cohort of Swedish patients | 16280042 | GSE1456B_DOC | ||
| GSE1460A | Gene Expression Profile during human CD4+ T cell differentiation | 15210650 | GSE1460A_DOC | ||
| GSE1460B | Gene Expression Profile during human CD4+ T cell differentiation | 15210650 | GSE1460B_DOC | ||
| GSE1462 | Mitochondrial disorders | 15728662 | GSE1462_DOC | ||
| GSE1466A | Expression profiles of ATL patients | GSE1466A_DOC | |||
| GSE1466B | Expression profiles of ATL patients | GSE1466B_DOC | |||
| GSE1469 | A549 lung pneumocytes cell line infected with wildtype and deletion mutation PAK strain Pseudomonas aeruginosa | 16207250 | GSE1469_DOC | ||
| GSE1470 | Epithelial stem cells co-cultured with the dermal papilla | 15292489 | GSE1470_DOC | ||
| GSE1473 | Beta-catenin/GFP | GSE1473_DOC | |||
| GSE1474 | Caco-2 and T84 cells stimulated with with flagellin, lymphotox beta or TNF alpha | GSE1474_DOC | |||
| GSE1481 | LCCS vs control comparison | 16155903 | GSE1481_DOC | ||
| GSE1485 | Natural variation in human gene expression | 15269782 | GSE1485_DOC | ||
| GSE1493 | Hematopoietic stem cell subsets | 15790771 | GSE1493_DOC | ||
| GSE1518 | Human endothelium exposed to shear stress and pressure | 16155357 | GSE1518_DOC | ||
| GSE1541 | A549 parenchymal cell activation | 15454581 | GSE1541_DOC | ||
| GSE1542A | Expression profile of pancreatic ductal cells | 16053509 | GSE1542A_DOC | ||
| GSE1542B | Expression profile of pancreatic ductal cells | 16053509 | GSE1542B_DOC | ||
| GSE1551 | dermatomyositis | 15852401 | GSE1551_DOC | ||
| GSE1561 | EORTC 10994 clinical trial | 15897907 | GSE1561_DOC | ||
| GSE1562 | Adenovirus-mediated E2F-1 gene transfer in melanoma cell line | 15656974 | GSE1562_DOC | ||
| GSE1563 | Kidney Transplant Rejection and Tissue Injury by Gene Profiling of Biopsies and Peripheral Blood Lymphocytes | 15307835 | GSE1563_DOC | ||
| GSE1572 | Gene regulation and DNA damage in the aging human brain | 15190254 | GSE1572_DOC | ||
| GSE1577 | T-ALL and T-lymphoblastic lymphoma | 16358311 | GSE1577_DOC | ||
| GSE1595 | Human bladder smooth muscle cells - effect of stretch in vitro | 15467014 | GSE1595_DOC | ||
| GSE1614 | Caco-2 differentiation | 12644633 | GSE1614_DOC | ||
| GSE1615A | Theca cell gene expression | 15598877 | GSE1615A_DOC | ||
| GSE1615B | Theca cell gene expression | 15598877 | GSE1615B_DOC | ||
| GSE1629 | Carious versus healthy pulp gene expression | 15869869 | GSE1629_DOC | ||
| GSE1643 | Normal Variance of Gene Expression in the Human Lung | 16498083 | GSE1643_DOC | ||
| GSE1644 | Leukotriene D4-triggered Transcriptome | 15322539 | GSE1644_DOC | ||
| GSE1648 | Osmotic Loading of Human Intervertebral Disc Cells | GSE1648_DOC | |||
| GSE1650 | COPD Study | 15374838 | GSE1650_DOC | ||
| GSE1657A | Adipocyte Differentiation | GSE1657A_DOC | |||
| GSE1657B | Adipocyte Differentiation | GSE1657B_DOC | |||
| GSE1676 | DNA damage response (NCS treatment) in several siRNA-manipulated cellular systems | 15892871 | GSE1676_DOC | ||
| GSE1682 | Global gene expression analysis of human glioma (Hs 683) cell lines exposed to candoxin | 16309724 | GSE1682_DOC | ||
| GSE1692 | T98G growth arrest | 15525513 | GSE1692_DOC | ||
| GSE1703 | Determination of mRNA transcripts in HeLa cells that are regulated by RENT1 | 15448691 | GSE1703_DOC | ||
| GSE1709 | STS107 T-cell activation at 1g vs. vg | 16210397 | GSE1709_DOC | ||
| GSE1719 | Macular Degeneration | GSE1719_DOC | |||
| GSE1724 | TGFbeta lung fibroblasts | GSE1724_DOC | |||
| GSE1725 | Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage | 15096622 | GSE1725_DOC | ||
| GSE1729 | Gene expression profile of acute myeloid leukemia | 15674361 | GSE1729_DOC | ||
| GSE1739 | SARS | GSE1739_DOC | |||
| GSE1740 | Tassiulas IFN Array v1.0 | 15467722 | GSE1740_DOC | ||
| GSE1743 | De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function | GSE1743_DOC | |||
| GSE1746 | CD14+ cell analysis | GSE1746_DOC | |||
| GSE1751 | Human blood expression for Huntington's disease versus control | 16043692 | GSE1751_DOC | ||
| GSE1764A | Effect of Oxandrolone on Muscle in Duchenne Muscular Dystrophy | 16263771 | GSE1764A_DOC | ||
| GSE1764B | Effect of Oxandrolone on Muscle in Duchenne Muscular Dystrophy | 16263771 | GSE1764B_DOC | ||
| GSE1786 | Vastus lateralis biopsies from healthy trained and sedentary males | 16260967 | GSE1786_DOC | ||
| GSE1789 | heart gene expression in Down syndrome | GSE1789_DOC | |||
| GSE1792 | Melanoma progression model: Differential Gene Expression | 15958521 | GSE1792_DOC | ||
| GSE1793 | Melanoma progression model:DAC-mediated gene expression | 15958521 | GSE1793_DOC | ||
| GSE1801 | Human hematopoietic stem cell engraftment in goat | 16682618 | GSE1801_DOC | ||
| GSE1802 | CBCD34-TGFbeta targets | 15477587 | GSE1802_DOC | ||
| GSE1805 | TGFbeta targets in M091 cell line | 15477587 | GSE1805_DOC | ||
| GSE1815 | The Influence of Interferon Gamma on Gene Expression in Normal Human Bronchial Epithelial Cells | 15985639 | GSE1815_DOC | ||
| GSE1822 | EWS-FLI1-transfection of HEK293 | 15548687 | GSE1822_DOC | ||
| GSE1823 | IL-2 transfection of A673-cells | 15170886 | GSE1823_DOC | ||
| GSE1824 | Neuroblastoma cell lines | 15548687 | GSE1824_DOC | ||
| GSE1825 | SRBCT | 15548687 | GSE1825_DOC | ||
| GSE1832 | Time and Exercise effects on Human Skeletal Muscle | 14519196 | GSE1832_DOC | ||
| GSE1845 | Melanoma cell lines | 15967107 | GSE1845_DOC | ||
| GSE1848A | lung and tonsillar mast cells | 15470070 | GSE1848A_DOC | ||
| GSE1848B | lung and tonsillar mast cells | 15470070 | GSE1848B_DOC | ||
| GSE1849A | Differential Gene Expression in Pulmonary Artery Endothelial Cells Exposed to Sickle Cell Plasma | 15741505 | GSE1849A_DOC | ||
| GSE1849B | Differential Gene Expression in Pulmonary Artery Endothelial Cells Exposed to Sickle Cell Plasma | 15741505 | GSE1849B_DOC | ||
| GSE1862 | The search for enzymes responsible for metabolism of nucleoside analogs | GSE1862_DOC | |||
| GSE1869 | Ischemic and Nonischemic CM and NF Hearts | 15769906 | GSE1869_DOC | ||
| GSE1880 | Role of LANA in KSHV latent infection | 15525642 | GSE1880_DOC | ||
| GSE1907 | Sarcoidosis + Follow-up study | GSE1907_DOC | |||
| GSE1910 | Microarray analysis of activated mixed glial (microglia) and monocyte-derived macrophage gene expression. | 15579277 | GSE1910_DOC | ||
| GSE1919 | Rheumatoid arthritis | GSE1919_DOC | |||
| GSE1922 | Leukemia study / K562 cell line | GSE1922_DOC | |||
| GSE1923 | Identification of PDGF-dependent patterns of gene expression in U87 glioblastoma cells | 15994924 | GSE1923_DOC | ||
| GSE1925 | IFN-gamma priming | 16148108 | GSE1925_DOC | ||
| GSE1926 | Carboplatin Sensitivity in Ovarian Carcinoma | 16227411 | GSE1926_DOC | ||
| GSE1933 | Mast Cell_time series | 16911805 | GSE1933_DOC | ||
| GSE1937 | Collagen-GAG Biocompatibility Tests | GSE1937_DOC | |||
| GSE1955 | Gene expression changes induced by K-ras oncogene in the human pancreatic duct epithelial cell line (H6c7) | GSE1955_DOC | |||
| GSE1977 | Portrait of transcriptional responses to ultraviolet and ionizing radiation in human cells | 15356296 | GSE1977_DOC | ||
| GSE1982 | PBMCs from CCI-779 Treated RCC subjects | GSE1982_DOC | |||
| GSE1987 | Non Small Cell Lung Cancer | GSE1987_DOC | |||
| GSE2004 | scien-affy-human-87089 | GSE2004_DOC | |||
| GSE2006 | Comparative microarray between normal and essential thrombocythemia platelets | 16113833 | GSE2006_DOC | ||
| GSE2018 | Human Lung Transplant - BAL | GSE2018_DOC | |||
| GSE2034 | Breast cancer relapse free survival | 15721472 | GSE2034_DOC | ||
| GSE2040 | Human endothelial progenitor cells (EPC) vs. human umbilical vein endothelial cells (HUVEC) vs. CD14+ monocytes | 15665831 | GSE2040_DOC | ||
| GSE2044A | Combining gene expression data from different generations of oligonucleotide arrays | 15504239 | GSE2044A_DOC | ||
| GSE2044B | Combining gene expression data from different generations of oligonucleotide arrays | 15504239 | GSE2044B_DOC | ||
| GSE2049 | AML1-ETO target genes | 15731354 | GSE2049_DOC | ||
| GSE2060B | Characterize CREB target genes in different tissue types | 15753290 | GSE2060B_DOC | ||
| GSE2060C | Characterize CREB target genes in different tissue types | 15753290 | GSE2060C_DOC | ||
| GSE2067 | HCV_Core_Study | 16876223 | GSE2067_DOC | ||
| GSE207 | HDMTX_MP-1 pair | 12704389 | GSE207_DOC | ||
| GSE2077 | Gene expression in Cryptosporidium parvum-infected human ileocecal adenocarcinoma cells (HCT-8) | 14711592 | GSE2077_DOC | ||
| GSE208 | HDMTX_MP-10 pair | 12704389 | GSE208_DOC | ||
| GSE209 | HDMTX_MP-2 pair | 12704389 | GSE209_DOC | ||
| GSE2099 | control-ethanol liver RNA | 15705656 | GSE2099_DOC | ||
| GSE210 | HDMTX_MP-3 pair | 12704389 | GSE210_DOC | ||
| GSE2109 | Expression Project for Oncology (expO) | GSE2109_DOC | |||
| GSE211 | HDMTX_MP-4 pair | 12704389 | GSE211_DOC | ||
| GSE2110 | Marrow-derived Mesenchymal stem cells(2004/12/24) | 15923633 | GSE2110_DOC | ||
| GSE2111 | Metal and Gene Expression | 16330358 | GSE2111_DOC | ||
| GSE2113 | Plasma cell dyscrasias expression profiles associated with distinct IGH translocations in multiple myeloma | 15735737 | GSE2113_DOC | ||
| GSE2117 | CALM-AF10 T-ALL | 16107895 | GSE2117_DOC | ||
| GSE212 | HDMTX_MP-5 pair | 12704389 | GSE212_DOC | ||
| GSE2125 | isolated alveolar macrophages | 16166618 | GSE2125_DOC | ||
| GSE213 | HDMTX_MP-6 pair | 12704389 | GSE213_DOC | ||
| GSE2135 | Filaria induced monocyte dysfunction and its reversal following treatment | 16861626 | GSE2135_DOC | ||
| GSE2138A | Colon cancer profiling | 16247484 | GSE2138A_DOC | ||
| GSE2138B | Colon cancer profiling | 16247484 | GSE2138B_DOC | ||
| GSE214 | HDMTX_MP-7 pair | 12704389 | GSE214_DOC | ||
| GSE2144 | Gene induction by low pH in oesophageal cells | 16113055 | GSE2144_DOC | ||
| GSE2149 | Gene Expression Profile of Primary Effusion Lymphoma | GSE2149_DOC | |||
| GSE215 | HDMTX_MP-8 pair | 12704389 | GSE215_DOC | ||
| GSE2152 | The effect of FH mutations on fibroid expression profile | 16319128 | GSE2152_DOC | ||
| GSE216 | HDMTX_MP-9 pair | 12704389 | GSE216_DOC | ||
| GSE2164 | Gender-specific gene expression in post-mortem human brain | 14583743 | GSE2164_DOC | ||
| GSE217 | HDMTX-1 pair | 12704389 | GSE217_DOC | ||
| GSE2171 | HIV-1 infection in human PBMCs in vivo | 15897992 | GSE2171_DOC | ||
| GSE2174 | D4-ME effects | GSE2174_DOC | |||
| GSE2175 | Differential gene expression in pituitary adenomas by oligonucleotide array analysis | 15994756 | GSE2175_DOC | ||
| GSE218 | HDMTX-10 pair | 12704389 | GSE218_DOC | ||
| GSE2189 | A549 teatement with MGd | GSE2189_DOC | |||
| GSE219 | HDMTX-11 pair | 12704389 | GSE219_DOC | ||
| GSE2191 | pediatric AML and normal bone marrow | 12738660 | GSE2191_DOC | ||
| GSE220 | HDMTX-12 pair | 12704389 | GSE220_DOC | ||
| GSE2208 | gene expression study of blood monocytes | 15965235 | GSE2208_DOC | ||
| GSE221 | HDMTX-13 pair | 12704389 | GSE221_DOC | ||
| GSE222 | HDMTX-14 pair | 12704389 | GSE222_DOC | ||
| GSE2222 | FoxM1 siRNA profiles | 15958562 | GSE2222_DOC | ||
| GSE2225 | Letrozole-, Anastrozole- and Tamoxifen-Responsive Genes in MCF-7aro Cells | 15831674 | GSE2225_DOC | ||
| GSE223 | HDMTX-15 pair | 12704389 | GSE223_DOC | ||
| GSE2230 | Effects of hTERT overexpression on gene expression profiles in CD4+ T lymphocytes | 15741219 | GSE2230_DOC | ||
| GSE2232 | Caco-2 cells cocultured with E.coli Nissle 1917 | 16351713 | GSE2232_DOC | ||
| GSE2238 | Targets of cytostatic drugs in HT1080 fibrosarcoma | 16001973 | GSE2238_DOC | ||
| GSE224 | HDMTX-16 pair | 12704389 | GSE224_DOC | ||
| GSE2240A | Comparison of atrial tissue of patients with atrial fibrillation and sinus rhythm with ventricular gene expression | 15877233 | GSE2240A_DOC | ||
| GSE2240B | Comparison of atrial tissue of patients with atrial fibrillation and sinus rhythm with ventricular gene expression | 15877233 | GSE2240B_DOC | ||
| GSE2241 | HOXA5 transcriptional targets | 15757903 | GSE2241_DOC | ||
| GSE2248 | Human Mesenchymal stem cell | 15971941 | GSE2248_DOC | ||
| GSE225 | HDMTX-17 pair | 12704389 | GSE225_DOC | ||
| GSE2251 | Anti-prolif. effect of E2 in breast cancer cells that re-exp. ERalpha is mediated by aberr. regulat. of cell cycle genes | 15821115 | GSE2251_DOC | ||
| GSE2256 | Lens Epithelial Cells and Lens Cortical Fiber Cells | 15851978 | GSE2256_DOC | ||
| GSE226 | HDMTX-18 pair | 12704389 | GSE226_DOC | ||
| GSE227 | HDMTX-19 pair | 12704389 | GSE227_DOC | ||
| GSE228 | HDMTX-2 pair | 12704389 | GSE228_DOC | ||
| GSE2280 | Prediction of lymphatic metastasis from primary squamous cell carcinoma of the oral cavity | 15558013 | GSE2280_DOC | ||
| GSE229 | HDMTX-20 pair | 12704389 | GSE229_DOC | ||
| GSE2292 | U2OS-ERa, U2OS-ERb, and U2OS-ERab cells treated with 4HT or E2 | 15802376 | GSE2292_DOC | ||
| GSE2294 | A Modular Analysis of Breast Cancer Reveals a Novel Low-Grade Molecular Signature in Estrogen Receptor-Positive Tumors | 16740749 | GSE2294_DOC | ||
| GSE2298 | hGSTA4-4 transfection in HLE B-3 experiment | 16005854 | GSE2298_DOC | ||
| GSE2299A | Egr-1 induced gene expression changes in HUVECs | 16818645 | GSE2299A_DOC | ||
| GSE2299B | Egr-1 induced gene expression changes in HUVECs | 16818645 | GSE2299B_DOC | ||
| GSE230 | HDMTX-21 pair | 12704389 | GSE230_DOC | ||
| GSE231 | HDMTX-22 pair | 12704389 | GSE231_DOC | ||
| GSE232 | HDMTX-3 pair | 12704389 | GSE232_DOC | ||
| GSE2322 | Expression changes induced by transmigration in human neutrophils | 16861384 | GSE2322_DOC | ||
| GSE2326A | Suqamous Cell Carcinoma of Head and Neck | GSE2326A_DOC | |||
| GSE2326B | Suqamous Cell Carcinoma of Head and Neck | GSE2326B_DOC | |||
| GSE2327 | siRNA mediated WTAP knockdown in HUVEC | GSE2327_DOC | |||
| GSE2328A | Application of genome-wide expression analysis to human health & disease | 15781863 | GSE2328A_DOC | ||
| GSE2328B | Application of genome-wide expression analysis to human health & disease | 15781863 | GSE2328B_DOC | ||
| GSE233 | HDMTX-4 pair | 12704389 | GSE233_DOC | ||
| GSE234 | HDMTX-5 pair | 12704389 | GSE234_DOC | ||
| GSE235 | HDMTX-6 pair | 12704389 | GSE235_DOC | ||
| GSE2350 | Normal and transformed human mature B cells | 15778709 | GSE2350_DOC | ||
| GSE2351 | chemotherapy cross-resistance and treatment response in childhood acute lymphoblastic leukemia | GSE2351_DOC | |||
| GSE236 | HDMTX-7 pair | 12704389 | GSE236_DOC | ||
| GSE237 | HDMTX-8 pair | 12704389 | GSE237_DOC | ||
| GSE238 | HDMTX-9 pair | 12704389 | GSE238_DOC | ||
| GSE239 | LDMTX_MP-1 pair | 12704389 | GSE239_DOC | ||
| GSE240 | LDMTX_MP-10 pair | 12704389 | GSE240_DOC | ||
| GSE241 | LDMTX_MP-11 pair | 12704389 | GSE241_DOC | ||
| GSE242 | LDMTX_MP-12 pair | 12704389 | GSE242_DOC | ||
| GSE2429 | Atypical Ductal Hyperplasia | 15864312 | GSE2429_DOC | ||
| GSE243 | LDMTX_MP-13 pair | 12704389 | GSE243_DOC | ||
| GSE244 | LDMTX_MP-14 pair | 12704389 | GSE244_DOC | ||
| GSE2443 | Prostate cancer - comparison of androgen-dependent and -independent microdissected primary tumor | 16203770 | GSE2443_DOC | ||
| GSE245 | LDMTX_MP-15 pair | 12704389 | GSE245_DOC | ||
| GSE246 | LDMTX_MP-16 pair | 12704389 | GSE246_DOC | ||
| GSE247 | LDMTX_MP-2 pair | 12704389 | GSE247_DOC | ||
| GSE248 | LDMTX_MP-3 pair | 12704389 | GSE248_DOC | ||
| GSE249 | LDMTX_MP-4 pair | 12704389 | GSE249_DOC | ||
| GSE250 | LDMTX_MP-5 pair | 12704389 | GSE250_DOC | ||
| GSE251 | LDMTX_MP-6 pair | 12704389 | GSE251_DOC | ||
| GSE252 | LDMTX_MP-7 pair | 12704389 | GSE252_DOC | ||
| GSE253 | LDMTX_MP-8 pair | 12704389 | GSE253_DOC | ||
| GSE254 | LDMTX_MP-9 pair | 12704389 | GSE254_DOC | ||
| GSE255 | MP-1 pair | 12704389 | GSE255_DOC | ||
| GSE2552 | Mapping Determinants of Human Gene Expression by Regional and Whole Genome Association | 16251966 | GSE2552_DOC | ||
| GSE256 | MP-10 pair | 12704389 | GSE256_DOC | ||
| GSE257 | MP-11 pair | 12704389 | GSE257_DOC | ||
| GSE258 | MP-12 pair | 12704389 | GSE258_DOC | ||
| GSE259 | MP-2 pair | 12704389 | GSE259_DOC | ||
| GSE260 | MP-3 pair | 12704389 | GSE260_DOC | ||
| GSE2603 | Subpopulations of MDA-MB-231 and Primary Breast Cancers | 16049480 | GSE2603_DOC | ||
| GSE261 | MP-4 pair | 12704389 | GSE261_DOC | ||
| GSE262 | MP-5 pair | 12704389 | GSE262_DOC | ||
| GSE263 | MP-6 pair | 12704389 | GSE263_DOC | ||
| GSE264 | MP-7 pair | 12704389 | GSE264_DOC | ||
| GSE265 | MP-8 pair | 12704389 | GSE265_DOC | ||
| GSE266 | MP-9 pair | 12704389 | GSE266_DOC | ||
| GSE267 | LDMTX_MP | 12704389 | GSE267_DOC | ||
| GSE268 | HDMTX | 12704389 | GSE268_DOC | ||
| GSE269 | HDMTX_MP | 12704389 | GSE269_DOC | ||
| GSE270 | MP | 12704389 | GSE270_DOC | ||
| GSE2724 | The effect of FH mutations on fibroid expression profile, normal myometrium vs. FH-mutant fibroids. | 16319128 | GSE2724_DOC | ||
| GSE281 | Inflammatory myopathy | 12391344 | GSE281_DOC | ||
| GSE2990 | Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis | 16478745 | GSE2990_DOC | ||
| GSE3013 | Actions of tamoxifen in the uterus and its molecular effectors in endometrial carcinogenesis. | 16355216 | GSE3013_DOC | ||
| GSE3141 | Lung Cancer Dataset | 16273092 | GSE3141_DOC | ||
| GSE3143 | Breast Cancer Dataset | 16273092 | GSE3143_DOC | ||
| GSE3156 | Breast Cancer Cell Lines | 16273092 | GSE3156_DOC | ||
| GSE3185A | Human Glioblastoma | GSE3185A_DOC | |||
| GSE3185B | Human Glioblastoma | GSE3185B_DOC | |||
| GSE3188A | Hypoxic regulation of gene expression is dominated by the HIF system and can be mimicked by DMOG | 16565084 | GSE3188A_DOC | ||
| GSE3188B | Hypoxic regulation of gene expression is dominated by the HIF system and can be mimicked by DMOG | 16565084 | GSE3188B_DOC | ||
| GSE349 | Resistant | 12907009 | GSE349_DOC | ||
| GSE3494A | An expression signature for p53 in breast cancer predicts mutation status, transcriptional effects, and patient survival | 16141321 | GSE3494A_DOC | ||
| GSE3494B | An expression signature for p53 in breast cancer predicts mutation status, transcriptional effects, and patient survival | 16141321 | GSE3494B_DOC | ||
| GSE350 | Sensitive | 12907009 | GSE350_DOC | ||
| GSE3529 | Profiling of three different ER+ breast cancer cell lines grown in the presence and absence of estrogen. | 15986123 | GSE3529_DOC | ||
| GSE3542 | Profiling of MCF-7 cell lines stably overexpressing (ca)Raf-1, (ca)MEK, (ca)erbB-2, or ligand-activatable EGFR. | 16585219 | GSE3542_DOC | ||
| GSE3589 | Leukotriene D4- and Thrombin-Triggered Transcriptomes in Human Umbilical Vein Endothelial Cells | 16606835 | GSE3589_DOC | ||
| GSE360 | Macrophages and dendritic cells exposed to phylogenetically distinct parasites | 12663451 | GSE360_DOC | ||
| GSE3744 | Human breast tumor expression | 16473279 | GSE3744_DOC | ||
| GSE3834A | Profiling of ER+ BrC cells with and without estradiol in both cell cultures and xenografts | GSE3834A_DOC | |||
| GSE3834B | Profiling of ER+ BrC cells with and without estradiol in both cell cultures and xenografts | GSE3834B_DOC | |||
| GSE3893A | Gene Expression Profiling of matched Ductal Carcinomas in Situ and Invasive Breast Tumors | 16707453 | GSE3893A_DOC | ||
| GSE3893B | Gene Expression Profiling of matched Ductal Carcinomas in Situ and Invasive Breast Tumors | 16707453 | GSE3893B_DOC | ||
| GSE3894 | Heterozygous carriers of Nijmegen Breakage Syndrome Have a Distinct Gene Expression Phenotype. | 16809669 | GSE3894_DOC | ||
| GSE4006 | Estrogen effects on MCF-7 breast cancer cells co-expressing ERa and ERb | 16809442 | GSE4006_DOC | ||
| GSE4025 | Gene Expression Preferentially Regulated by Tamoxifen in Breast Cancer Cells | 16849584 | GSE4025_DOC | ||
| GSE412 | Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells | 12704389 | GSE412_DOC | ||
| GSE420 | Aortic stiffness | 14530203 | GSE420_DOC | ||
| GSE427 | Human Fibroblast Set: Hacia Laboratory | 12840040 | GSE427_DOC | ||
| GSE4292 | PTHrP-responsive genes in breast cancer | 16551631 | GSE4292_DOC | ||
| GSE430 | Effect of left ventricular assist device support on congestive heart failure patients | 12824457 | GSE430_DOC | ||
| GSE443 | Leprosy lesion gene expression | 12970564 | GSE443_DOC | ||
| GSE448 | WS1 response to high dose of UV-C | 12907719 | GSE448_DOC | ||
| GSE449 | WS1 response to low dose of UV-C | 12907719 | GSE449_DOC | ||
| GSE4573 | Gene expression signatures for predicting prognosis of squamous cell lung carcinomas | 16885343 | GSE4573_DOC | ||
| GSE465A | Expression profiling in the muscular dystrophies | 11121445 | GSE465A_DOC | ||
| GSE465B | Expression profiling in the muscular dystrophies | 11121445 | GSE465B_DOC | ||
| GSE465C | Expression profiling in the muscular dystrophies | 11121445 | GSE465C_DOC | ||
| GSE465D | Expression profiling in the muscular dystrophies | 11121445 | GSE465D_DOC | ||
| GSE465E | Expression profiling in the muscular dystrophies | 11121445 | GSE465E_DOC | ||
| GSE4668 | Expression data from hormone-starved MCF7/BUS cell culture | 14610279 | GSE4668_DOC | ||
| GSE468 | Expression profiling of medulloblastoma | 11544480 | GSE468_DOC | ||
| GSE4922A | Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer | GSE4922A_DOC | |||
| GSE4922B | Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer | GSE4922B_DOC | |||
| GSE493A | Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis | 11937576 | GSE493A_DOC | ||
| GSE500 | CD34+ cell analysis | 11669215 | GSE500_DOC | ||
| GSE5102 | Genomic profile of the estrogen induced neoplastic transformation of the human breast epithelial cell MCF10F | GSE5102_DOC | |||
| GSE511 | Proliferating normal human peripheral blood mononuclear cells infected with HIV type 1 RF | 11839152 | GSE511_DOC | ||
| GSE516 | TNF treated Synoviocytes | 12965196 | GSE516_DOC | ||
| GSE5327 | Breast cancer relapse free survival and lung metastasis free survival | 17420468 | GSE5327_DOC | ||
| GSE567 | Essential Thrombocythemia (ET) vs Normal (baseline) Megakaryocytes | 15271793 | GSE567_DOC | ||
| GSE574 | Idiopathic thrombocytopenic purpura (ITP) | 12937414 | GSE574_DOC | ||
| GSE5859A | Allelic Differences Account for Gene Expression Differences Among Population. | 17206142 | GSE5859A_DOC | ||
| GSE590 | USF1 haplotype comparison | 14991056 | GSE590_DOC | ||
| GSE595 | Human skeletal muscle | 14625377 | GSE595_DOC | ||
| GSE609A | SCID vs Normal Thymocyte Comparisons | 14602880 | GSE609A_DOC | ||
| GSE609B | SCID vs Normal Thymocyte Comparisons | 14602880 | GSE609B_DOC | ||
| GSE620A | Gene expression profile analysis of 4-phenylbutyrate treatment of IB3-1 bronchial epithelial cell line | 14583596 | GSE620A_DOC | ||
| GSE620B | Gene expression profile analysis of 4-phenylbutyrate treatment of IB3-1 bronchial epithelial cell line | 14583596 | GSE620B_DOC | ||
| GSE6253A | A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer | 17194181 | GSE6253A_DOC | ||
| GSE6253B | A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer | 17194181 | GSE6253B_DOC | ||
| GSE6253C | A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer | 17194181 | GSE6253C_DOC | ||
| GSE635 | Identification of novel genomic determinants of cellular drug resistance in acute lymphoblastic leukemia. | 15295046 | GSE635_DOC | ||
| GSE6429 | HGPC, in monolayer, 0.5 vs. 20% serum, complete | GSE6429_DOC | |||
| GSE643 | ASP sensitive all ALL | 15295046 | GSE643_DOC | ||
| GSE6434 | Docetaxel treatment of sensitve and resistant patients | GSE6434_DOC | |||
| GSE645 | ASP resistant all ALL | 15295046 | GSE645_DOC | ||
| GSE646 | PRED sensitive all ALL | 15295046 | GSE646_DOC | ||
| GSE647 | PRED resistant all ALL | 15295046 | GSE647_DOC | ||
| GSE648 | VCR sensitive all ALL | 15295046 | GSE648_DOC | ||
| GSE649 | VCR resistant all ALL | 15295046 | GSE649_DOC | ||
| GSE64A | Insulin sensitive muscle sample pool 1 | 12436343 | GSE64A_DOC | ||
| GSE64B | Insulin sensitive muscle sample pool 1 | 12436343 | GSE64B_DOC | ||
| GSE64C | Insulin sensitive muscle sample pool 1 | 12436343 | GSE64C_DOC | ||
| GSE64D | Insulin sensitive muscle sample pool 1 | 12436343 | GSE64D_DOC | ||
| GSE64E | Insulin sensitive muscle sample pool 1 | 12436343 | GSE64E_DOC | ||
| GSE650 | DNR sensitive all ALL | 15295046 | GSE650_DOC | ||
| GSE651 | DNR resistant all ALL | 15295046 | GSE651_DOC | ||
| GSE653 | ASP sensitive B-ALL | 15295046 | GSE653_DOC | ||
| GSE6532A | Definition of clinically distinct molecular subtypes in estrogen receptor positive breast carcinomas using genomic grade | 17401012 | GSE6532A_DOC | ||
| GSE6532B | Definition of clinically distinct molecular subtypes in estrogen receptor positive breast carcinomas using genomic grade | 17401012 | GSE6532B_DOC | ||
| GSE6532C | Definition of clinically distinct molecular subtypes in estrogen receptor positive breast carcinomas using genomic grade | 17401012 | GSE6532C_DOC | ||
| GSE654 | ASP resistant B-ALL | 15295046 | GSE654_DOC | ||
| GSE655 | PRED sensitive B-ALL | 15295046 | GSE655_DOC | ||
| GSE656 | PRED resistant B-ALL | 15295046 | GSE656_DOC | ||
| GSE657 | VCR sensitive B-ALL | 15295046 | GSE657_DOC | ||
| GSE658 | VCR resistant B-ALL | 15295046 | GSE658_DOC | ||
| GSE659 | DNR sensitive B-ALL | 15295046 | GSE659_DOC | ||
| GSE65A | Insulin sensitive muscle sample pool 2 | 12436343 | GSE65A_DOC | ||
| GSE65B | Insulin sensitive muscle sample pool 2 | 12436343 | GSE65B_DOC | ||
| GSE65C | Insulin sensitive muscle sample pool 2 | 12436343 | GSE65C_DOC | ||
| GSE65D | Insulin sensitive muscle sample pool 2 | 12436343 | GSE65D_DOC | ||
| GSE65E | Insulin sensitive muscle sample pool 2 | 12436343 | GSE65E_DOC | ||
| GSE660 | DNR resistant B-ALL | 15295046 | GSE660_DOC | ||
| GSE6604A | Expression data from Normal Prostate Tissue free of any pathological alteration | 17430594 | GSE6604A_DOC | ||
| GSE6604B | Expression data from Normal Prostate Tissue free of any pathological alteration | 17430594 | GSE6604B_DOC | ||
| GSE6604C | Expression data from Normal Prostate Tissue free of any pathological alteration | 17430594 | GSE6604C_DOC | ||
| GSE6605A | Expression data from Metastatic Prostate Tumor | 17430594 | GSE6605A_DOC | ||
| GSE6605B | Expression data from Metastatic Prostate Tumor | 17430594 | GSE6605B_DOC | ||
| GSE6605C | Expression data from Metastatic Prostate Tumor | 17430594 | GSE6605C_DOC | ||
| GSE6606A | Expression data from Primary Prostate Tumor | 17430594 | GSE6606A_DOC | ||
| GSE6606B | Expression data from Primary Prostate Tumor | 17430594 | GSE6606B_DOC | ||
| GSE6606C | Expression data from Primary Prostate Tumor | 17430594 | GSE6606C_DOC | ||
| GSE6608A | Expression data from Normal Prostate Tissue Adjacent to Tumor | 17430594 | GSE6608A_DOC | ||
| GSE6608B | Expression data from Normal Prostate Tissue Adjacent to Tumor | 17430594 | GSE6608B_DOC | ||
| GSE6608C | Expression data from Normal Prostate Tissue Adjacent to Tumor | 17430594 | GSE6608C_DOC | ||
| GSE66A | Insulin sensitive muscle sample pool 3 | 12436343 | GSE66A_DOC | ||
| GSE66B | Insulin sensitive muscle sample pool 3 | 12436343 | GSE66B_DOC | ||
| GSE66C | Insulin sensitive muscle sample pool 3 | 12436343 | GSE66C_DOC | ||
| GSE66D | Insulin sensitive muscle sample pool 3 | 12436343 | GSE66D_DOC | ||
| GSE66E | Insulin sensitive muscle sample pool 3 | 12436343 | GSE66E_DOC | ||
| GSE675 | Time course analysis of response to HCMV infection | 11711622 | GSE675_DOC | ||
| GSE67A | Insulin sensitive muscle sample pool 4 | 12436343 | GSE67A_DOC | ||
| GSE67B | Insulin sensitive muscle sample pool 4 | 12436343 | GSE67B_DOC | ||
| GSE67C | Insulin sensitive muscle sample pool 4 | 12436343 | GSE67C_DOC | ||
| GSE67D | Insulin sensitive muscle sample pool 4 | 12436343 | GSE67D_DOC | ||
| GSE67E | Insulin sensitive muscle sample pool 4 | 12436343 | GSE67E_DOC | ||
| GSE685 | DACH1 inhibits TGF-beta signaling through binding Smad4 | 14525983 | GSE685_DOC | ||
| GSE68A | Insulin sensitive muscle sample pool 5 | 12436343 | GSE68A_DOC | ||
| GSE68B | Insulin sensitive muscle sample pool 5 | 12436343 | GSE68B_DOC | ||
| GSE68C | Insulin sensitive muscle sample pool 5 | 12436343 | GSE68C_DOC | ||
| GSE68D | Insulin sensitive muscle sample pool 5 | 12436343 | GSE68D_DOC | ||
| GSE68E | Insulin sensitive muscle sample pool 5 | 12436343 | GSE68E_DOC | ||
| GSE6919A | Expression Data from Normal and Prostate Tumor Tissues | 17430594 | GSE6919A_DOC | ||
| GSE6919B | Expression Data from Normal and Prostate Tumor Tissues | 17430594 | GSE6919B_DOC | ||
| GSE6919C | Expression Data from Normal and Prostate Tumor Tissues | 17430594 | GSE6919C_DOC | ||
| GSE69A | Insulin resistant muscle sample pool 1 | 12436343 | GSE69A_DOC | ||
| GSE69B | Insulin resistant muscle sample pool 1 | 12436343 | GSE69B_DOC | ||
| GSE69C | Insulin resistant muscle sample pool 1 | 12436343 | GSE69C_DOC | ||
| GSE69D | Insulin resistant muscle sample pool 1 | 12436343 | GSE69D_DOC | ||
| GSE69E | Insulin resistant muscle sample pool 1 | 12436343 | GSE69E_DOC | ||
| GSE701 | Transcriptional response of lymphoblastoid cells to ionizing radiation | 12915489 | GSE701_DOC | ||
| GSE703 | Blood pulmonary arterial hypertension | 15215156 | GSE703_DOC | ||
| GSE70A | Insulin resistant muscle sample pool 2 | 12436343 | GSE70A_DOC | ||
| GSE70B | Insulin resistant muscle sample pool 2 | 12436343 | GSE70B_DOC | ||
| GSE70C | Insulin resistant muscle sample pool 2 | 12436343 | GSE70C_DOC | ||
| GSE70D | Insulin resistant muscle sample pool 2 | 12436343 | GSE70D_DOC | ||
| GSE70E | Insulin resistant muscle sample pool 2 | 12436343 | GSE70E_DOC | ||
| GSE713 | UV radiation-induced DNA damage | 12907719 | GSE713_DOC | ||
| GSE71A | Insulin resistant muscle sample pool 3 | 12436343 | GSE71A_DOC | ||
| GSE71B | Insulin resistant muscle sample pool 3 | 12436343 | GSE71B_DOC | ||
| GSE71C | Insulin resistant muscle sample pool 3 | 12436343 | GSE71C_DOC | ||
| GSE71D | Insulin resistant muscle sample pool 3 | 12436343 | GSE71D_DOC | ||
| GSE71E | Insulin resistant muscle sample pool 3 | 12436343 | GSE71E_DOC | ||
| GSE72A | Insulin resistant muscle sample pool 4 | 12436343 | GSE72A_DOC | ||
| GSE72B | Insulin resistant muscle sample pool 4 | 12436343 | GSE72B_DOC | ||
| GSE72C | Insulin resistant muscle sample pool 4 | 12436343 | GSE72C_DOC | ||
| GSE72D | Insulin resistant muscle sample pool 4 | 12436343 | GSE72D_DOC | ||
| GSE72E | Insulin resistant muscle sample pool 4 | 12436343 | GSE72E_DOC | ||
| GSE7307 | Human body index - transcriptional profiling | GSE7307_DOC | |||
| GSE7390 | Strong Time Dependence of the 76-Gene Prognostic Signature | 17545524 | GSE7390_DOC | ||
| GSE73A | Insulin resistant muscle sample pool 5 | 12436343 | GSE73A_DOC | ||
| GSE73B | Insulin resistant muscle sample pool 5 | 12436343 | GSE73B_DOC | ||
| GSE73C | Insulin resistant muscle sample pool 5 | 12436343 | GSE73C_DOC | ||
| GSE73D | Insulin resistant muscle sample pool 5 | 12436343 | GSE73D_DOC | ||
| GSE73E | Insulin resistant muscle sample pool 5 | 12436343 | GSE73E_DOC | ||
| GSE753 | MRI-no-lytic-lesion | 14695408 | GSE753_DOC | ||
| GSE754 | MRI-lytic-lesion | 14695408 | GSE754_DOC | ||
| GSE755 | MRI lytic and no lytic lesions | 14695408 | GSE755_DOC | ||
| GSE758 | Gene expression in human optic nerve head (ONH) astrocytes | 14747662 | GSE758_DOC | ||
| GSE764 | Comparison of Gene Expression in Uterine Smooth Muscle Tumors | GSE764_DOC | |||
| GSE781A | Normal and Renal Cell Carcinoma Kidney Tissue, Human | 14641932 | GSE781A_DOC | ||
| GSE781B | Normal and Renal Cell Carcinoma Kidney Tissue, Human | 14641932 | GSE781B_DOC | ||
| GSE803A | GeneNote-Gene Normal tissue Expression | 15388519 | GSE803A_DOC | ||
| GSE803B | GeneNote-Gene Normal tissue Expression | 15388519 | GSE803B_DOC | ||
| GSE803C | GeneNote-Gene Normal tissue Expression | 15388519 | GSE803C_DOC | ||
| GSE803D | GeneNote-Gene Normal tissue Expression | 15388519 | GSE803D_DOC | ||
| GSE803E | GeneNote-Gene Normal tissue Expression | 15388519 | GSE803E_DOC | ||
| GSE8218 | Gene expression data from prostate cancer samples | GSE8218_DOC | |||
| GSE846 | Conversion | 14702632 | GSE846_DOC | ||
| GSE847 | HS to HR progression | 14702632 | GSE847_DOC | ||
| GSE848 | E2 and SERM Treatment of MCF-7 Breast Cancer Cells | 14973112 | GSE848_DOC | ||
| GSE88 | Bladder tumour recurrence prediction | 12469123 | GSE88_DOC | ||
| GSE89 | Bladder tumour stage classification | 12469123 | GSE89_DOC | ||
| GSE923 | Pseudomonas aeruginosa infection of Calu-3 human lung epithelial cells | 15494517 | GSE923_DOC | ||
| GSE935 | NIH/NIAID Chronic Granulomatous Disease Neutrophils | 14688376 | GSE935_DOC | ||
| GSE96 | Large-scale analysis of the human transcriptome | 11904358 | GSE96_DOC | ||
| GSE973 | IL-1 stimulation of HUVEC | 15130917 | GSE973_DOC | ||
| GSE974 | Left ventricular apex samples | 14872006 | GSE974_DOC | ||
| GSE976 | Gene Expression-Based High Throughput Screening: APL Treatment with Candidate Compounds | 14770183 | GSE976_DOC | ||
| GSE981 | Endothelin-1 (ET-1) treated lung fibroblasts | GSE981_DOC | |||
| GSE982 | Gene Expression-Based High Throughput Screening: HL-60 Cell Treatment with Candidate Compounds | 14770183 | GSE982_DOC | ||
| GSE983 | Gene Expression-Based High Throughput Screening: Primary Patient AML Blasts, Normal Neutrophils, and Normal Monocytes | 14770183 | GSE983_DOC | ||
| GSE985 | Gene Expression-Based High Throughput Screening: HL-60 Cells Treated with ATRA and PMA | 14770183 | GSE985_DOC | ||
| GSE995A | Differentiation of acute myeloid leukemia cells | 14770183 | GSE995A_DOC | ||
| GSE995B | Differentiation of acute myeloid leukemia cells | 14770183 | GSE995B_DOC | ||
| GSE997 | Essential Thrombocythemia megakaryocytes versus normal megakaryocytes | 15271793 | GSE997_DOC | ||
| GSE998 | Amino Acid Conjugated Surfaces and Controls 6 Hours | GSE998_DOC | |||
| GSE999 | Amino Acid Conjugated Surfaces and Controls 32 Hours | GSE999_DOC | |||
| BASIC 33 | C0001 | Classification of human astrocytic gliomas | 14583454 | C0001_DOC | |
| GSE1361 | Concurrent Versus Individual Binding of HuR and AUF1 to Common Labile Target mRNAs | 15257295 | GSE1361_DOC | ||
| GSE137 | Natural variation in human gene expression assessed in lymphoblastoid cells | 12567189 | GSE137_DOC | ||
| GSE1433 | TIAR represses c-Myc biosynthesis following ultraviolet light irradiation | 16537914 | GSE1433_DOC | ||
| GSE1434 | HaCaT +GLI1/2 24/72h | 16434164 | GSE1434_DOC | ||
| GSE1440 | TIAR represses c-Myc biosynthesis following ultraviolet light irradiation-2 | GSE1440_DOC | |||
| GSE1510 | Human UniGene Set RZPD 1 - Zipf's Normalization | GSE1510_DOC | |||
| GSE1511 | Gene expression profile of CD56dimCD16+, CD56brightCD16- and activated CD56+CD16+ human NK subsets | 15557145 | GSE1511_DOC | ||
| GSE1710 | Expression profiling in inflammatory bowel disease | 16107186 | GSE1710_DOC | ||
| GSE1748 | VI-28 treatment induced alteration of gene expression in human lymphocytes | GSE1748_DOC | |||
| GSE1767 | Human blood expression for Huntington's disease versus control, Codelink | 16043692 | GSE1767_DOC | ||
| GSE1836 | Comparison of native versus cultured RPE cells | 16234463 | GSE1836_DOC | ||
| GSE2046 | Hep3B time-course | GSE2046_DOC | |||
| GSE2052 | IPF versus Control | 16128620 | GSE2052_DOC | ||
| GSE2053 | RAvs.ND | GSE2053_DOC | |||
| GSE2075 | Rosetta_miRNA_transfection_experiment | 15685193 | GSE2075_DOC | ||
| GSE2097 | Epigenetic treatment of cervical carcinoma cell lines | 16434596 | GSE2097_DOC | ||
| GSE2143 | Human coronary artery study | 15942018 | GSE2143_DOC | ||
| GSE2177 | Trascriptional profiling of angiogenic inhibitors | 12499246 | GSE2177_DOC | ||
| GSE2182 | Drug treatment comparison | GSE2182_DOC | |||
| GSE2243 | RIZ1 repression is associated with insulin-like growth factor-1 signaling activation in chronic myeloid leukemia... | 16953217 | GSE2243_DOC | ||
| GSE2845 | Human breast tumor | GSE2845_DOC | |||
| GSE3155A | Gene expression profiling of the 20 human early breast carcinomas by three miaroarray platforms | GSE3155A_DOC | |||
| GSE3155B | Gene expression profiling of the 20 human early breast carcinomas by three miaroarray platforms | GSE3155B_DOC | |||
| GSE3155C | Gene expression profiling of the 20 human early breast carcinomas by three miaroarray platforms | GSE3155C_DOC | |||
| GSE3570 | cDNA array of the new human breast cancer cell line EM-G3 derived from breast cancer progenitor cells | GSE3570_DOC | |||
| GSE4056 | Expression profiling of human primary breast cancer tissue before treatment with gemcitabine, epirubicine and docetaxel | 16622258 | GSE4056_DOC | ||
| GSE465F | Expression profiling in the muscular dystrophies | 11121445 | GSE465F_DOC | ||
| GSE4716A | Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients | 15064725 | GSE4716A_DOC | ||
| GSE4716B | Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients | 15064725 | GSE4716B_DOC | ||
| GSE4882 | A Gene Expression Signature to Predict Metastasis and Survival in Non-small Cell Lung Cancer | 17202451 | GSE4882_DOC | ||
| GSE493B | Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis | 11937576 | GSE493B_DOC | ||
| GSE6752 | CodeLink Expression Data from primary prostate tumor and prostate tumor metastases | 17430594 | GSE6752_DOC | ||
| COUNTS 23 | GSE10 | eye-SAGE | 11756676 | GSE10_DOC | |
| GSE14 | CGAP SAGE | 11257097 | GSE14_DOC | ||
| GSE1439 | Differentiation of cultured THP-1 cells | GSE1439_DOC | |||
| GSE17 | Young and old muscle comparison | 10904065 | GSE17_DOC | ||
| GSE1747 | Human 32 MPSS samples | GSE1747_DOC | |||
| GSE1902 | Cancer Genome Anatomy Project (Human: longSAGE) | GSE1902_DOC | |||
| GSE2017 | Genomic alterations in primary hyperaldosteronism | 16204365 | GSE2017_DOC | ||
| GSE2055 | Human Adrenal Cortex affected by Primary Pigmented Nodular Adrenocortical Disease | GSE2055_DOC | |||
| GSE2056 | PBECs stimulated with pro-inflammatory cytokines and P. aeruginosa | 15701729 | GSE2056_DOC | ||
| GSE2346 | The pattern of gene expression in human CD34(+) stem/progenitor cells | 11717454 | GSE2346_DOC | ||
| GSE278 | Pancreas and islet gene expression | GSE278_DOC | |||
| GSE31 | SAGE_HumanEpidermis | 11772949 | GSE31_DOC | ||
| GSE41 | Effects of estrogen | 11085516 | GSE41_DOC | ||
| GSE505 | Serial analysis of gene expression in the corneal endothelium of Fuchs' dystrophy | 12556388 | GSE505_DOC | ||
| GSE506 | Fibroblast cells immediate-early after human cytomegalovirus infection | 11124023 | GSE506_DOC | ||
| GSE507 | Novel estrogen and tamoxifen induced genes | 11850811 | GSE507_DOC | ||
| GSE508 | Targets of c-Jun NH(2)-terminal kinase 2-mediated tumor growth regulation | 12036942 | GSE508_DOC | ||
| GSE514 | AIDS-related Kaposi's sarcoma | 12697073 | GSE514_DOC | ||
| GSE545 | SAGE Hiroshima gastric cancer tissue | 15059891 | GSE545_DOC | ||
| GSE608 | Human embryonic stem cells | 14688391 | GSE608_DOC | ||
| GSE694 | SADE analysis of microdissected kidney | 14595018 | GSE694_DOC | ||
| GSE953 | Effect of TERT and ATM on Gene Expression Profiles in Human Fibroblasts | 14978791 | GSE953_DOC | ||
| HSEST | Tissue break-down of ESTs derived from Unigene clusters | 8849440 | HSEST_DOC | ||
| CUSTOM | GSE1133B | tissue-specific pattern of mRNA expression | 15075390 | GSE1133B_DOC | |
| DUAL 106 | GSE1 | NHGRI_Melanoma_class | 10952317 | GSE1_DOC | |
| GSE1030A | H295RAII3h | 15375197 | GSE1030A_DOC | ||
| GSE1030B | H295RAII3h | 15375197 | GSE1030B_DOC | ||
| GSE1037 | Lung cancer | GSE1037_DOC | |||
| GSE1039 | Differential Gene Expression by Memory T Helper Cells Bearing the Gut-Homing Receptor Integrin beta 7+ and beta 7- | 15236665 | GSE1039_DOC | ||
| GSE1041 | Responses of HUVEC to Hypoxia and Reoxygenation | GSE1041_DOC | |||
| GSE105 | Lipopolysaccharide-stimulated neutrophils | 12495940 | GSE105_DOC | ||
| GSE1054 | EP300 knock-out image segmentation | 15028803 | GSE1054_DOC | ||
| GSE1057 | Human lupus and normal CD4 T cells response to anti-CD3 treatment | GSE1057_DOC | |||
| GSE112A | Distinctive gene expression patterns in gastrointestinal stromal tumors identified with cDNA arrays | GSE112A_DOC | |||
| GSE112B | Distinctive gene expression patterns in gastrointestinal stromal tumors identified with cDNA arrays | GSE112B_DOC | |||
| GSE1276 | Effect of cigarette smoke on normal human bronchial epithelial cells, and S9 toxicity | 15326394 | GSE1276_DOC | ||
| GSE1279 | Tubular carcinoma and adenoma | 15800983 | GSE1279_DOC | ||
| GSE1288 | Cytokine Stimulated Vs Unstimulated | GSE1288_DOC | |||
| GSE1291 | Adenovirus vs Mock Infection | GSE1291_DOC | |||
| GSE1292 | HSP27 3A vs WT | GSE1292_DOC | |||
| GSE1319 | Immunohistochemical and Clinical Characterization of the Basal-like Subtype | 15328174 | GSE1319_DOC | ||
| GSE1366 | Total-body irradiation dose response | 15374940 | GSE1366_DOC | ||
| GSE1369 | Sham-irradiated vs pool of sham-irradiated keratinocytes | 15691830 | GSE1369_DOC | ||
| GSE1370 | Irradiated vs sham irradiated keratynocytes | 15691830 | GSE1370_DOC | ||
| GSE1378 | breast cancer / tamoxifen monotherapy (microdissected tumor biopsies) | 15193263 | GSE1378_DOC | ||
| GSE1379 | breast cancer / tamoxifen monotherapy (whole tissue tumor biopsies) | 15193263 | GSE1379_DOC | ||
| GSE1406 | vGPCR and lytic KSHV time course in TIME cells | 15289507 | GSE1406_DOC | ||
| GSE1484 | PDGF stimulation kinetics | 15213220 | GSE1484_DOC | ||
| GSE1486 | Steroids_Effect_on_HUVEC_Response_to_LPS_or_Cytokines | GSE1486_DOC | |||
| GSE1487 | DU 145 EMETINE TIME COURSE | 15300251 | GSE1487_DOC | ||
| GSE1488 | LNCaP EMETINE TIME COURSE | 15300251 | GSE1488_DOC | ||
| GSE1489 | PC3 EMETINE TIME COURSE | 15300251 | GSE1489_DOC | ||
| GSE1490 | GM00156 EMETINE TIME COURSE | 15300251 | GSE1490_DOC | ||
| GSE1545 | Human podocyte differentiation | GSE1545_DOC | |||
| GSE1549 | Intestinal cells infected with Vibrio cholerae | 15213169 | GSE1549_DOC | ||
| GSE1645 | TAcKLE - Transcriptome Amplification and cDNA Labeling for Expression analysis | 15718295 | GSE1645_DOC | ||
| GSE1647 | Prediction of toxicant-specific gene expression signatures following chemotherapeutic treatment of breast cell lines | 15598611 | GSE1647_DOC | ||
| GSE1694 | Promyelocytic cells response to Anaplasma phagocytophilum infection | 15760455 | GSE1694_DOC | ||
| GSE1704 | Epithelial cells in contact with bacterial supernatant | 15598879 | GSE1704_DOC | ||
| GSE1705 | EGFR inhibitors block basal-like breast cancer growth | GSE1705_DOC | |||
| GSE1715 | mCGH of cervical cancer | GSE1715_DOC | |||
| GSE1718 | Pre- and Post-training arrays/Insulin sensitivity response | 15687108 | GSE1718_DOC | ||
| GSE1726 | Rosetta_Merck_CEPH_Study | 15514893 | GSE1726_DOC | ||
| GSE1755 | Array-based comparative genomic hybridization for distinguishing paraffin-embedded Spitz nevi and melanomas | 15163005 | GSE1755_DOC | ||
| GSE1818 | Testicular germ cell tumors and their histological subgroups | 15994931 | GSE1818_DOC | ||
| GSE1827 | Waldman Bladder tumors | GSE1827_DOC | |||
| GSE1864 | A genomic view of estrogen actions in human breast cancer cells | 15171711 | GSE1864_DOC | ||
| GSE1898 | Human Hepatocellular Carcinoma study | 15565109 | GSE1898_DOC | ||
| GSE1900 | Immortalization of normal human cells | 15942647 | GSE1900_DOC | ||
| GSE1991 | Array-CGH in human glial brain tumors | 15899798 | GSE1991_DOC | ||
| GSE1992 | A New Breast Tumor Intrinsic Gene List Identifies Novel Characteristics that are Conserved Across Microarray Platforms | 16643655 | GSE1992_DOC | ||
| GSE2003 | NCI cDNA microarray-human 60 cell lines | 10700174 | GSE2003_DOC | ||
| GSE2014 | Molecular classification of failing hearts from coronary and myopathic patients | GSE2014_DOC | |||
| GSE2020 | Differential Gene Up-regulation by HIF-1a and HIF-2a in HEK293T. | 15833863 | GSE2020_DOC | ||
| GSE2035 | Hearts_DD_Screening | GSE2035_DOC | |||
| GSE2047 | folic acid | GSE2047_DOC | |||
| GSE2048 | Breast Cancer: Invasive Ductal Carcinoma | GSE2048_DOC | |||
| GSE2051 | Hearts_tissue_expression_profile | GSE2051_DOC | |||
| GSE2058 | Identification of drug associated genes in ovarian cancer by RNA profiling | GSE2058_DOC | |||
| GSE2061 | Hearts_tissue_expression_profile_2 | GSE2061_DOC | |||
| GSE2062 | Hearts_tissue_expression_profile_3 | GSE2062_DOC | |||
| GSE2155 | Microarray Analysis of Gene Expression in Human Normal and Breast Cancer Cells | 15659406 | GSE2155_DOC | ||
| GSE2179 | Expression profiling of secreted and cell surface genes of 5 transformed cell lines and derivative xenograft tumors | GSE2179_DOC | |||
| GSE2193 | Normal_human_tissues | 15774023 | GSE2193_DOC | ||
| GSE2194 | Normal_human_tissues_genomic_controls | GSE2194_DOC | |||
| GSE2221 | Drug resistance in glioblastoma | 16365179 | GSE2221_DOC | ||
| GSE2223 | Gene expression profiling in human glial brain tumors | 16204036 | GSE2223_DOC | ||
| GSE2283A | Primary human neuroblastoma | 15837623 | GSE2283A_DOC | ||
| GSE2283B | Primary human neuroblastoma | 15837623 | GSE2283B_DOC | ||
| GSE2345 | Human TK6 cells treated with BPDE or N-OH-AABP yielding 5%, 15% and 40% of toxicity | GSE2345_DOC | |||
| GSE2584 | Gene expression patterns induced by 5-Fluorouracil in breast cancer cell lines | 16557594 | GSE2584_DOC | ||
| GSE2607 | Biological Classification of Breast Cancer by Real-Time Quantitative RTPCR: Comparisons to Microarray and Histopathology | 16626501 | GSE2607_DOC | ||
| GSE2740 | Estrogen-regulated genes predict survival in estrogen receptor and/or progesterone receptor-positive breast cancers | 16505416 | GSE2740_DOC | ||
| GSE2741 | Breast Tumor's study | 16230372 | GSE2741_DOC | ||
| GSE2987 | RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer | 11533059 | GSE2987_DOC | ||
| GSE3165A | Identification of conserved gene expression features across human and murine mammary tumors murine mammary tumors | GSE3165A_DOC | |||
| GSE3178 | Gene expression patterns associated with p53 status in breast cancer | 17150101 | GSE3178_DOC | ||
| GSE3192 | Partially degraded RNA from bladder washing is a suitable sample for studying gene expression profiles of bladder cancer | GSE3192_DOC | |||
| GSE3193 | Breast Tumor Clinical Implications | 11553815 | GSE3193_DOC | ||
| GSE3211 | Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia | 11733578 | GSE3211_DOC | ||
| GSE3281 | Breast Cancer aCGH | 12297621 | GSE3281_DOC | ||
| GSE3398 | Diversity of gene expression in adenocarcinoma of the lung. | 11707590 | GSE3398_DOC | ||
| GSE3521 | Analysis of breast tumors and metastases identify a molecular signature of the Warburg effect and fibroblast patterns | GSE3521_DOC | |||
| GSE3762A | Effects of Estrogen and Tamoxifen on Ishikawa cells after 24h and 48h | GSE3762A_DOC | |||
| GSE3762B | Effects of Estrogen and Tamoxifen on Ishikawa cells after 24h and 48h | GSE3762B_DOC | |||
| GSE3901 | Response of quiescent human fibroblasts to different growth factors and serum | GSE3901_DOC | |||
| GSE3933 | Prostate Cancer | 14711987 | GSE3933_DOC | ||
| GSE4027 | Prostate cancer cell line LNCaP treated for 2, 4, 6, 8 h with the synthetic androgen R1881 (1nM) | 16707422 | GSE4027_DOC | ||
| GSE425 | Acute myeloid leukemia study | 15084693 | GSE425_DOC | ||
| GSE4268 | Breast and ovarian carcinoma | 12960427 | GSE4268_DOC | ||
| GSE4335 | Norway/Stanford Breast Tumors | 12829800 | GSE4335_DOC | ||
| GSE4382 | Repeated observation of breast tumor subtypes in independent gene expression data sets | 12829800 | GSE4382_DOC | ||
| GSE53 | Human mammary epithelium and breast cancer | 10430922 | GSE53_DOC | ||
| GSE55 | Serum stimulation of fibroblasts experiment set | 9872747 | GSE55_DOC | ||
| GSE56 | Serum stimulation of fibroblasts with cycloheximide | 9872747 | GSE56_DOC | ||
| GSE57 | Serum stimulation of fibroblasts controls | 9872747 | GSE57_DOC | ||
| GSE58 | Serum stimulation of fibroblasts | 9872747 | GSE58_DOC | ||
| GSE5803 | gene differentially expressed in androgen independent prostate cancer | GSE5803_DOC | |||
| GSE5828 | Gene expression profiling classifies lung squamous cell carcinomas with N1 positive lymph nodes | 17601969 | GSE5828_DOC | ||
| GSE5843 | Expression profiling defines a recurrence signature in lung adenocarcinoma | 17082175 | GSE5843_DOC | ||
| GSE5859B | Allelic Differences Account for Gene Expression Differences Among Population. | 17206142 | GSE5859B_DOC | ||
| GSE60 | Diffuse large B-cell lymphoma | 10676951 | GSE60_DOC | ||
| GSE61 | Molecular portraits of human breast tumors | 10963602 | GSE61_DOC | ||
| GSE6128 | EGFR signaling varies with breast tumor subtype | 17663798 | GSE6128_DOC | ||
| GSE6130 | Agreement in Breast Cancer Classification between Microarray and qRT-PCR from Fresh-Frozen and Formalin-Fixed Tissues | GSE6130_DOC | |||
| GSE6131 | Role of E2F3 expression in human bladder and prostate cancer cells | 16909110 | GSE6131_DOC | ||
| GSE6250 | Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues | 17044071 | GSE6250_DOC | ||
| GSE763 | Cell-type specific responses to chemotherapeutics in breast cancer | 15205334 | GSE763_DOC | ||
| R0001 | Comparison and classification of breast cancers | 11823860 | R0001_DOC | ||
| R0002 | Survival in breast cancer. | 12490681 | R0002_DOC | ||
| Mouse 326 | AFFY 180 | GSE1008 | Extraocular muscle, comparison of wild type and mdx mice, 14 to 112 Days (Porter lab) | 12874102 | GSE1008_DOC |
| GSE1011 | Chronic Rosiglitazone Mouse Aorta | 15054141 | GSE1011_DOC | ||
| GSE1018 | Leg muscle mdx and control | GSE1018_DOC | |||
| GSE1025 | Hindlimb muscle, comparison of wild type and mdx mice, 7 to 112 Day (Porter lab) | 12874102 | GSE1025_DOC | ||
| GSE1026 | Diaphram, comparison of wild type and mdx mice, 7 to 112 Days (Porter lab) | 14681298 | GSE1026_DOC | ||
| GSE1049A | Cell Culture A and B chips EOM | 16291736 | GSE1049A_DOC | ||
| GSE1049B | Cell Culture A and B chips EOM | 16291736 | GSE1049B_DOC | ||
| GSE1050 | Difference in skeletal muscle function in Males vs Females; Role of Estrogen Receptor Beta | 15280152 | GSE1050_DOC | ||
| GSE1052A | Cell Culture A and B chips leg | 16291736 | GSE1052A_DOC | ||
| GSE1052B | Cell Culture A and B chips leg | 16291736 | GSE1052B_DOC | ||
| GSE106 | OVX/P4/UTX 129/SvImJ WT A | 12554760 | GSE106_DOC | ||
| GSE1062 | Extraocular, masticatory, and hindlimb muscles, comparison of putative muscle allotypes (Porter lab) | 11572940 | GSE1062_DOC | ||
| GSE107 | OVX/P4/UTX 129/SvImJ WT B | 12554760 | GSE107_DOC | ||
| GSE108 | OVX/P4/6h/UTX 129 WT vs. Hoxa-10-/- | 12554760 | GSE108_DOC | ||
| GSE1085 | Profiling of aggressive vs benign pancreatic infiltrates in the BDC2.5 Tg model of Type I diabetes | 15141080 | GSE1085_DOC | ||
| GSE1086 | Dwarf Ad libitum | GSE1086_DOC | |||
| GSE1087 | Dwarf Calorie Restricted | 15039484 | GSE1087_DOC | ||
| GSE1088 | Normal Ad Libitum | 15039484 | GSE1088_DOC | ||
| GSE1089 | Normal Calorie Restricted | 15039484 | GSE1089_DOC | ||
| GSE109 | OVX/oil/6h/UTX 129 WT vs. Hoxa-10-/- | 12554760 | GSE109_DOC | ||
| GSE1092 | SJL, Balb: Leg and Eye, 10/12 months | GSE1092_DOC | |||
| GSE1093 | caloric restriction | 15039484 | GSE1093_DOC | ||
| GSE1096 | Hair follicle stem cell gene profile | 15024388 | GSE1096_DOC | ||
| GSE1108 | Antisense IL-10 treatment in Malignant Murine B-1 Cells | GSE1108_DOC | |||
| GSE1112 | RTOC thymocytes | 15133507 | GSE1112_DOC | ||
| GSE1123 | C3H10T1/2 Adipogenesis: Effects of EGF and TCDD | GSE1123_DOC | |||
| GSE1131 | Osteoblast differentiation experiment: BMP-2 induced osteogenesis in mouse MC3T3 cell line | 15178686 | GSE1131_DOC | ||
| GSE1134 | Na,K-ATPase alpha 1 het. heart | GSE1134_DOC | |||
| GSE1143 | Insulin-like growth factor 1 (IGF1) heart study | 14597618 | GSE1143_DOC | ||
| GSE1148 | Sex Specific Transciption in Mouse Tissues | GSE1148_DOC | |||
| GSE117 | P7 wildtype | GSE117_DOC | |||
| GSE118 | P10 wildtype | GSE118_DOC | |||
| GSE119 | P14 wildtype | GSE119_DOC | |||
| GSE120 | P18 wildtype | GSE120_DOC | |||
| GSE122 | P21 wildtype | GSE122_DOC | |||
| GSE123 | P7 knockout | GSE123_DOC | |||
| GSE124 | P10 knockout | GSE124_DOC | |||
| GSE125 | P14 knockout | GSE125_DOC | |||
| GSE126 | P18 knockout | GSE126_DOC | |||
| GSE127 | P21 knockout | GSE127_DOC | |||
| GSE128 | Rp1 knockout mice retinal development | 16126734 | GSE128_DOC | ||
| GSE1281 | Expression profile of genes in normal and Down syndrome mouse brains MGU74A | 15138197 | GSE1281_DOC | ||
| GSE1282 | Expression profile of genes in normal and Down syndrome mouse brains MGU74B | 15138197 | GSE1282_DOC | ||
| GSE1283 | KPAW and wild type eyes | GSE1283_DOC | |||
| GSE1294A | Expression profile of genes in normal and Down syndrome mouse brains | 15138197 | GSE1294A_DOC | ||
| GSE1294B | Expression profile of genes in normal and Down syndrome mouse brains | 15138197 | GSE1294B_DOC | ||
| GSE1301A | PGA Murine IL-13 Asthma | GSE1301A_DOC | |||
| GSE1301B | PGA Murine IL-13 Asthma | GSE1301B_DOC | |||
| GSE1303 | PGA Murine Lung Estrogen | GSE1303_DOC | |||
| GSE1308 | Effects of ethanol on poly IC gene induction | 15294990 | GSE1308_DOC | ||
| GSE1321 | Hypoxic response in wild type and HIF-1alpha null hepatoctyes | GSE1321_DOC | |||
| GSE135 | Erythroid Progenitor Cell Gene Expression Profiles | GSE135_DOC | |||
| GSE1358A | Embryonic Testis Developmental Time Course | 15496517 | GSE1358A_DOC | ||
| GSE1358B | Embryonic Testis Developmental Time Course | 15496517 | GSE1358B_DOC | ||
| GSE1358C | Embryonic Testis Developmental Time Course | 15496517 | GSE1358C_DOC | ||
| GSE1359A | Embryonic Ovary Developmental Time Course | 15496517 | GSE1359A_DOC | ||
| GSE1359B | Embryonic Ovary Developmental Time Course | 15496517 | GSE1359B_DOC | ||
| GSE1359C | Embryonic Ovary Developmental Time Course | 15496517 | GSE1359C_DOC | ||
| GSE1363 | Gene expression in T1alpha null mutant lungs compared to wild type at dpc 18.5 and term | GSE1363_DOC | |||
| GSE1375 | PS cDKO / Control, 6 months | 15345711 | GSE1375_DOC | ||
| GSE1381 | Snell Dwarf Response to 3-NPA | GSE1381_DOC | |||
| GSE1382 | IL10-/-DC + 0,SEA,LPS,SEA/LPS 6H | 15585871 | GSE1382_DOC | ||
| GSE1391 | Preimplantation mouse embryo development U74Av2 | 15282163 | GSE1391_DOC | ||
| GSE1392 | Comparison of conventional and germ-free gastrointestinal tract | 15226484 | GSE1392_DOC | ||
| GSE1399A | Zfp145 spermatogonia | 15156143 | GSE1399A_DOC | ||
| GSE1399B | Zfp145 spermatogonia | 15156143 | GSE1399B_DOC | ||
| GSE1399C | Zfp145 spermatogonia | 15156143 | GSE1399C_DOC | ||
| GSE13A | Murine bone marrow B cell precursors | 11779835 | GSE13A_DOC | ||
| GSE13B | Murine bone marrow B cell precursors | 11779835 | GSE13B_DOC | ||
| GSE1419 | Pancreatic T regulatory vs. T effector cells | 15184501 | GSE1419_DOC | ||
| GSE1423 | Global analysis of genes differentially expressed in branching and non-branching regions of the mouse embryonic lung | 15328023 | GSE1423_DOC | ||
| GSE1435 | Microarray Based Comparison of two Amplification Methods For Nanogram Amounts of Total RNA | 15613496 | GSE1435_DOC | ||
| GSE1437 | F9 cells after exposure to RA or TSA | 15467438 | GSE1437_DOC | ||
| GSE1448 | Engagement of TCR with antibodies | 15661827 | GSE1448_DOC | ||
| GSE1457 | CxVB3 infection and cardiac function | GSE1457_DOC | |||
| GSE1458 | Pioglitazone, rosiglitazone and troglitazone treatment | 15217816 | GSE1458_DOC | ||
| GSE1459 | LPS effects on macrophages | 15640147 | GSE1459_DOC | ||
| GSE1463 | Extraocular, hindlimb, and cardiac muscles, comparison of dko and mdx mice (Porter lab) | 16525850 | GSE1463_DOC | ||
| GSE1468 | Hepatic reductase null | GSE1468_DOC | |||
| GSE1471 | Cardiac muscle, comparisons of wild type and mdx mice, 8 week and 10.5 month (Porter lab) | GSE1471_DOC | |||
| GSE1472 | Extraocular and hindlimb muscle, comparison of wild type and mdx mice, 56 days (Porter lab) | 11823445 | GSE1472_DOC | ||
| GSE1479 | C57BL/6 Benchmark Set for Early Cardiac Development | GSE1479_DOC | |||
| GSE1482 | Murine Neurofibromatosis | GSE1482_DOC | |||
| GSE1552 | gene activation by IFNs in wild type and Pias1 null BMMs | 15311277 | GSE1552_DOC | ||
| GSE1555 | Vehicle and sAPPalpha-treated hippocampal slice cultures | 15342738 | GSE1555_DOC | ||
| GSE1556 | Control vs. APPSw mice gene expressions | GSE1556_DOC | |||
| GSE1559 | HSC 5-FU time course | 15459755 | GSE1559_DOC | ||
| GSE1565 | Ezh2 deficiency in double negative thymocytes | GSE1565_DOC | |||
| GSE1566 | Ezh2 deficient T-cell | GSE1566_DOC | |||
| GSE1569 | Keratinocytes in embryos and newborns, and Notch1 expression in newborns | 15068794 | GSE1569_DOC | ||
| GSE1571 | Muscle and Bone marrow SP and MP cells | GSE1571_DOC | |||
| GSE1576 | Subconfluent and confluent aortic endothelial cells | GSE1576_DOC | |||
| GSE1578A | Naive and memory B6.2.16 CD8 T cell(11K A and B) | 15311278 | GSE1578A_DOC | ||
| GSE1578B | Naive and memory B6.2.16 CD8 T cell(11K A and B) | 15311278 | GSE1578B_DOC | ||
| GSE1579 | Conditional activation of B-catenin in adult mouse epidermis for 0, 1, or 7 days | 15992546 | GSE1579_DOC | ||
| GSE1584 | EP - GMP | 15522951 | GSE1584_DOC | ||
| GSE1588 | 27_RA_RMA_Jan04_time_course | 15466718 | GSE1588_DOC | ||
| GSE1606 | Whole brain gene expression in X-monosomic and normal female mice | 15908953 | GSE1606_DOC | ||
| GSE1611 | Transcriptome of Ts1Cje and euploids cerebellum | 15590701 | GSE1611_DOC | ||
| GSE1621 | Differential expression of genes after 48 hrs, 10 d, and 3 wks of TAC | 15292486 | GSE1621_DOC | ||
| GSE1623 | NOD.scid, NOD, BDC2.5/NOD and BDC2.5/NOD.scid mice | 15671250 | GSE1623_DOC | ||
| GSE1624 | Murine orofacial development | GSE1624_DOC | |||
| GSE1659 | Time series of diabetes and exercise training induced expression changes in skeletal muscle of mice | 16352670 | GSE1659_DOC | ||
| GSE1674 | BPH and BPL mouse strain adrenal glands | 15882546 | GSE1674_DOC | ||
| GSE1680 | Effect of CCL3 on target ablation-induced macrophage recruitment into the olfactory epithelium | 15467013 | GSE1680_DOC | ||
| GSE1708 | Comparison of transcriptional changes in Cre infected with Vector infected alpha4-floxed MEFs | GSE1708_DOC | |||
| GSE1727 | Isolation and angiogenesis by endothelial progenitors in the fetal liver | 16099996 | GSE1727_DOC | ||
| GSE1744 | Preimplantation mouse embryo development MOE430A | 15282163 | GSE1744_DOC | ||
| GSE1745 | Preimplantation mouse embryo development MOE430B | 15282163 | GSE1745_DOC | ||
| GSE1749A | Preimplantation mouse embryo development | 15282163 | GSE1749A_DOC | ||
| GSE1749B | Preimplantation mouse embryo development | 15282163 | GSE1749B_DOC | ||
| GSE1749C | Preimplantation mouse embryo development | 15282163 | GSE1749C_DOC | ||
| GSE1772 | Soleus muscle | 16199803 | GSE1772_DOC | ||
| GSE1776 | Control and starved myotubes | 15608089 | GSE1776_DOC | ||
| GSE1791 | Effect of Neuromedin U on gene expression in murine T cells | 15585845 | GSE1791_DOC | ||
| GSE1800 | Murine Spastic Spinal Cord | GSE1800_DOC | |||
| GSE1806 | Skeletal muscle allotypes | GSE1806_DOC | |||
| GSE1809 | Cardiac grafts pteridine cyclosporinA and NIL treated | 16495807 | GSE1809_DOC | ||
| GSE1811 | response to HDI | 15885264 | GSE1811_DOC | ||
| GSE1819 | Induction of similar multistage transcriptional responses in the mouse uterus by E2 and GEN | 15289156 | GSE1819_DOC | ||
| GSE1830A | Identification of spinal cord fusimotor neuron-specific genes.Tourtellotte-5R01NS040748-03-2 | GSE1830A_DOC | |||
| GSE1830B | Identification of spinal cord fusimotor neuron-specific genes.Tourtellotte-5R01NS040748-03-2 | GSE1830B_DOC | |||
| GSE1835 | Myocilin effect on retina. Russell-7U24NS043571-02 | GSE1835_DOC | |||
| GSE1839 | Equivalence of biologic responses induced in the mouse uterus by E2, GEN, and DES | 15289156 | GSE1839_DOC | ||
| GSE1847 | Boswellia Serrata | 15539433 | GSE1847_DOC | ||
| GSE1852 | Fibrillin-1 deficient mice | 15546004 | GSE1852_DOC | ||
| GSE1867 | mouse corneal stromal cells | 15452052 | GSE1867_DOC | ||
| GSE1871 | SCCOR_MouseLung_Simva_LPS | 15665042 | GSE1871_DOC | ||
| GSE1873 | The effect of intermittent hypoxia on gene expression in the liver of ob/ob mice | 16037401 | GSE1873_DOC | ||
| GSE1886 | Murine Müllerian duct Day0 DES | GSE1886_DOC | |||
| GSE1899 | Targets of Wnt-1 in C57MG | 15794748 | GSE1899_DOC | ||
| GSE1906 | LPS induced gene expression in macrophages in the presence of Carbon monoxide | GSE1906_DOC | |||
| GSE1912 | Gene expression profiles of mouse back skin during the hair growth cycle | 15520371 | GSE1912_DOC | ||
| GSE1921 | Homeostatic Proliferation of OT-I T cells | 15548615 | GSE1921_DOC | ||
| GSE1936A | Epididymal fat tissues-DU6/DU6i-DUKs/DBA | GSE1936A_DOC | |||
| GSE1936B | Epididymal fat tissues-DU6/DU6i-DUKs/DBA | GSE1936B_DOC | |||
| GSE1940 | LGG treatment on YANC | 16306130 | GSE1940_DOC | ||
| GSE1947 | Disease mechanisms in peripheral neuropathies due to altered Pmp22 gene dosage or a Pmp22 point mutation | 15755691 | GSE1947_DOC | ||
| GSE1948 | SRF-VP16 overexpression in ES cells | GSE1948_DOC | |||
| GSE1949 | Time series serum stimulation of ES cells of different Srf genotype | GSE1949_DOC | |||
| GSE1956 | Mouse neuroblastoma Tcof1 | GSE1956_DOC | |||
| GSE1984 | Skeletal muscle cell differentiation | GSE1984_DOC | |||
| GSE1986 | Global gene expression across a range of tissues | GSE1986_DOC | |||
| GSE1988 | Exercise and transcriptional analysis in male eNOS Knockout Mice | 15879487 | GSE1988_DOC | ||
| GSE1998A | Genes regulated by Egr3 in primary myotubes. Tourtellotte-5R01NS040748-03 | GSE1998A_DOC | |||
| GSE1998B | Genes regulated by Egr3 in primary myotubes. Tourtellotte-5R01NS040748-03 | GSE1998B_DOC | |||
| GSE1999 | Neuroprotective effects of erythropoietin. Wilson-5R01NS028208-15 | GSE1999_DOC | |||
| GSE2002 | CstF-64 Influenced Gene Expression | 16207706 | GSE2002_DOC | ||
| GSE2005 | Hippocampus of HuD overexpressor mice. Perrone-Bizzozero-5R01NS030255-12 | GSE2005_DOC | |||
| GSE2019 | Microarray Based Comparison of three Amplification Methods For Nanogram Amounts of Total RNA | 15613496 | GSE2019_DOC | ||
| GSE2031 | Identification of genes and quantitative trait loci (QTL) that control hematopoietic stem cell functioning | GSE2031_DOC | |||
| GSE2039 | FACS purified cortical projection neurons | GSE2039_DOC | |||
| GSE2042A | Apoptosis and differentiation commitment:novel insights revealed by gene profiling studies in mouse Embryonic Stem cells | 16311515 | GSE2042A_DOC | ||
| GSE2042B | Apoptosis and differentiation commitment:novel insights revealed by gene profiling studies in mouse Embryonic Stem cells | 16311515 | GSE2042B_DOC | ||
| GSE2057 | Gene expression profiling and localization of Hoechst-effluxing CD45- and CD45+ cells in the Embryonic Mouse Lung | 16076931 | GSE2057_DOC | ||
| GSE2059 | IL-21/IL-15 regulation of CD8 T-cells | GSE2059_DOC | |||
| GSE2060A | Characterize CREB target genes in different tissue types | 15753290 | GSE2060A_DOC | ||
| GSE2060D | Characterize CREB target genes in different tissue types | 15753290 | GSE2060D_DOC | ||
| GSE2082 | ER stress time course (WT vs CHOP-/-) | 15601821 | GSE2082_DOC | ||
| GSE2084A | Effect of radiation on Oct-1 mutant and Wild Type Mouse strains | 16322220 | GSE2084A_DOC | ||
| GSE2084B | Effect of radiation on Oct-1 mutant and Wild Type Mouse strains | 16322220 | GSE2084B_DOC | ||
| GSE2118 | IR-response in Atm-/- and control lymph nodes | 16314843 | GSE2118_DOC | ||
| GSE2120 | Growth Hormone (GH) Treatment of 3T3-F442A Adipocytes | 16326703 | GSE2120_DOC | ||
| GSE2121 | Skeletal muscle of adrenalectomized mice with and without a glucocorticoid injection 3 or 24 h previously (MG-U74Av2) | 15716308 | GSE2121_DOC | ||
| GSE2123A | FDC-E vs FDC-D | 15843551 | GSE2123A_DOC | ||
| GSE2123B | FDC-E vs FDC-D | 15843551 | GSE2123B_DOC | ||
| GSE2123C | FDC-E vs FDC-D | 15843551 | GSE2123C_DOC | ||
| GSE2124A | sLTbetaR-Ig treated mLN | 15843551 | GSE2124A_DOC | ||
| GSE2124B | sLTbetaR-Ig treated mLN | 15843551 | GSE2124B_DOC | ||
| GSE2195 | Phenotypic Anchoring of Gene Expression Changes during Estrogen-Induced Uterine Growth | 15598610 | GSE2195_DOC | ||
| GSE2528 | Comparative Analysis of MMTV-neu tumors, preneoplastic MMTV-neu mammary gland, and Wild-type controls | 15897883 | GSE2528_DOC | ||
| GSE272A | T and B lymphocyte development profiles | 12538694 | GSE272A_DOC | ||
| GSE272B | T and B lymphocyte development profiles | 12538694 | GSE272B_DOC | ||
| GSE4140 | NF639 cells original population vs EGCG-resistant population | 16707458 | GSE4140_DOC | ||
| GSE5317 | Expression analysis of Day 0 versus Day 1 involuting mouse mammary gland | GSE5317_DOC | |||
| GSE6439 | OVX/P4&oil/UTX 129 WT vs. Hoxa-10-/- | GSE6439_DOC | |||
| GSE6440 | OVX/P4/UTX 129/SvImJ WT | GSE6440_DOC | |||
| GSE6821A | Global gene expression analysis of GMP from Icsbp (Irf-8) deficient mice | GSE6821A_DOC | |||
| GSE6821B | Global gene expression analysis of GMP from Icsbp (Irf-8) deficient mice | GSE6821B_DOC | |||
| GSE97 | Large-scale analysis of the mouse transcriptome | 11904358 | GSE97_DOC | ||
| BASIC 21 | GSE11 | NOD model of type 1 diabetes | 11827943 | GSE11_DOC | |
| GSE12 | Group1 | GSE12_DOC | |||
| GSE1284 | Control | GSE1284_DOC | |||
| GSE1285 | Hindlimb suspension | GSE1285_DOC | |||
| GSE1286 | Reloaded 1 day | GSE1286_DOC | |||
| GSE1287 | Reloaded 7 days | GSE1287_DOC | |||
| GSE1293 | Hindlimb suspension and reloading study | 15479860 | GSE1293_DOC | ||
| GSE1367 | Simulated Microgravity Inhibits Differentiation and Alters Gene Expression Profiles of 2T3 Pre-osteoblasts | GSE1367_DOC | |||
| GSE15 | Group2 | GSE15_DOC | |||
| GSE1503 | Male/Female BALB/c Mouse Submandibular/Sublingual/Parotid/Lacrimal/Meibomian Glands | 15668334 | GSE1503_DOC | ||
| GSE1536 | Various mouse cell lines and tissues | GSE1536_DOC | |||
| GSE1582 | Male BALB/c Mouse Testosterone-Treated Submandibular/Lacrimal/Meibomian Glands | 16186348 | GSE1582_DOC | ||
| GSE1678 | H2O2 treatment of myotubes | 15331678 | GSE1678_DOC | ||
| GSE1679 | Isometric contractions in skeletal muscle of adult mice | 15331678 | GSE1679_DOC | ||
| GSE1856 | Gene Analysis of Rasagiline | GSE1856_DOC | |||
| GSE1903 | Mouse tissue comparison | 15588312 | GSE1903_DOC | ||
| GSE2054 | Quantitative microarray profiling of alternative splicing in mouse tissues | GSE2054_DOC | |||
| GSE2066 | Genes regulated by FGF2 in mouse cortical neuron culture | GSE2066_DOC | |||
| GSE2168 | Mouse Immune system | 15504237 | GSE2168_DOC | ||
| GSE2178 | Mouse Expression DB 2001 CHMC | 15126645 | GSE2178_DOC | ||
| GSE2384 | Normoxia versus hypoxia exposure | GSE2384_DOC | |||
| COUNTS 30 | GSE1067 | MPSS analysis of mouse BLK CL.4 and liver cells | GSE1067_DOC | ||
| GSE1090 | Mouse cerebellum | 15246995 | GSE1090_DOC | ||
| GSE1091 | Adipose tissue of gonadectomized mice injected with dihydrotestosterone | 15525599 | GSE1091_DOC | ||
| GSE1316 | IL-10-conditioned dendritic cells elicit innate inflammatory gene products in response to danger signals | 14764687 | GSE1316_DOC | ||
| GSE1445 | Effect of potassium-depleted diet on kidney | 15238618 | GSE1445_DOC | ||
| GSE1446 | Control vs. AngII Infusion: Heart | 15242839 | GSE1446_DOC | ||
| GSE1465 | uranyl nitrate exposure | 15598614 | GSE1465_DOC | ||
| GSE1581 | MPSS mouse transcriptome analysis project | GSE1581_DOC | |||
| GSE1689 | Normal and injured liver sinusoidal endothelial cells | 15464976 | GSE1689_DOC | ||
| GSE1771 | Luteinisation genes | 15459113 | GSE1771_DOC | ||
| GSE1939 | Adult mouse testis | 15748293 | GSE1939_DOC | ||
| GSE1962 | mouse sciatic nerve profile of CMT1A peripheral neuropathy model, caused by PMP22 overexpression | 15672449 | GSE1962_DOC | ||
| GSE205 | Mouse T helper cell clones | 11801640 | GSE205_DOC | ||
| GSE206 | CD4/CD25 subsets of mouse spleen | 12023351 | GSE206_DOC | ||
| GSE2070 | SAGE: unfertilized eggs | GSE2070_DOC | |||
| GSE2122 | Skeletal muscle of glucocorticoid deprived and treated mice by SAGE | 15716308 | GSE2122_DOC | ||
| GSE348 | SAGE analysis of mouse brain regions | 12840043 | GSE348_DOC | ||
| GSE352 | Cerebellum of Lurcher (Lc +/-) mouse. | GSE352_DOC | |||
| GSE366 | Somatic cells in testes | 12748123 | GSE366_DOC | ||
| GSE42 | P19 embryonic carcinoma (EC) cells induced to form cardiomyocytes in vitro | 12204248 | GSE42_DOC | ||
| GSE4729 | The kidney collecting duct acid-base regulon | 16868073 | GSE4729_DOC | ||
| GSE504 | Comparative molecular analysis of developing mouse forelimbs and hindlimbs | 11591645 | GSE504_DOC | ||
| GSE606 | Control vs. AngII Infusion | 14570981 | GSE606_DOC | ||
| GSE652 | Chondrogenesis in ATDC5 cells | GSE652_DOC | |||
| GSE678 | Transcriptome of a mouse kidney cortical collecting duct cell line: effects of aldosterone and vasopressin | 11226305 | GSE678_DOC | ||
| GSE683 | Gene expression profiles in normal and Otx2-/- early gastrulating mouse embryos | 11114168 | GSE683_DOC | ||
| GSE786 | short and long attack latency mice | 12542675 | GSE786_DOC | ||
| GSE828 | genes/pathways underlying lipoprotein homeostasis | 11742874 | GSE828_DOC | ||
| GSE887 | Mus musculus cornea experiment | 14744882 | GSE887_DOC | ||
| MMEST | Tissue break-down of ESTs derived from Unigene clusters | 8849440 | MMEST_DOC | ||
| CUSTOM | GSE1133C | tissue-specific pattern of mRNA expression | 15075390 | GSE1133C_DOC | |
| DUAL 94 | GSE1013 | Gene Expression Profile of NHE1 Null Mutation | 15306696 | GSE1013_DOC | |
| GSE1014 | B cell response to CD40, Anti-IgM, ELC, IL4, terbutaline and lipopolysaccharide treatment | GSE1014_DOC | |||
| GSE1019 | B cell response to Anti-IgM and CD40 treatment | GSE1019_DOC | |||
| GSE1020 | B cell response to Anti-IgM and ELC treatment | GSE1020_DOC | |||
| GSE1021 | B cell response to Anti-IgM and terbutaline treatment | GSE1021_DOC | |||
| GSE1022 | B cell response to CD40 and lipopolysaccharide treatment | GSE1022_DOC | |||
| GSE1023 | B cell response to CD40 and IL4 treatment | GSE1023_DOC | |||
| GSE1024 | B cell response to ELC and lipopolysaccharide treatment | GSE1024_DOC | |||
| GSE1038 | In vivo LPS effects on cardiac endothelial RNA-15K cDNA array | 15319271 | GSE1038_DOC | ||
| GSE1042 | Cardiac endothelial in vivo responses to LPS | 15319271 | GSE1042_DOC | ||
| GSE1043 | In vitro LPS response of SVEC cells | 15319271 | GSE1043_DOC | ||
| GSE1044 | Endothelial in vivo vs. in vitro responses to LPS | 15319271 | GSE1044_DOC | ||
| GSE1058 | Reduced atherosclerosis in MyD88 null mice | 15034566 | GSE1058_DOC | ||
| GSE1098 | Effect of LPS and LPS-binding protein treatment on RAW 264.4 cells | 16982864 | GSE1098_DOC | ||
| GSE1099 | Effect of LPS and LPS-binding protein treatment for 1 hour on RAW 264.4 cells | GSE1099_DOC | |||
| GSE1100 | Effect of LPS and LPS-binding protein treatment for 2 hours on RAW 264.4 cells | GSE1100_DOC | |||
| GSE1101 | Effect of LPS and LPS-binding protein treatment for 4 hours on RAW 264.4 cells | GSE1101_DOC | |||
| GSE1102 | Effect of LPS and LPS-binding protein treatment for 8 hours on RAW 264.4 cells | GSE1102_DOC | |||
| GSE1103 | Effect of LPS and LPS-binding protein treatment for 16 hours on RAW 264.4 cells | GSE1103_DOC | |||
| GSE1104 | Effect of LPS and LPS-binding protein treatment for 48 hours on RAW 264.4 cells | GSE1104_DOC | |||
| GSE1109 | CEA_SGF:E00002#REtsAF-Bcl2_ZVAD | 15326223 | GSE1109_DOC | ||
| GSE1129 | Rb knockout retinal explant comparison | 14991054 | GSE1129_DOC | ||
| GSE1138 | Gene expression in mouse ovary and testis | 15156144 | GSE1138_DOC | ||
| GSE1150 | CEA_SGF:E00005#LIF | 16099994 | GSE1150_DOC | ||
| GSE1151 | CEA_SGF:E00004#TetOFF_Stat3F | 16099994 | GSE1151_DOC | ||
| GSE1290 | CEA_SGF:E00008#transgenic_IIb-tk | 15947096 | GSE1290_DOC | ||
| GSE1298 | Aquaporin-1 Knockout vs Wild type Mice | 15507545 | GSE1298_DOC | ||
| GSE1348 | HBC-3 matrigel differentiation | GSE1348_DOC | |||
| GSE1393A | A time course microarray study of gene expression in the mouse lacrimal gland after acute corneal trauma. | 15671270 | GSE1393A_DOC | ||
| GSE1393B | A time course microarray study of gene expression in the mouse lacrimal gland after acute corneal trauma. | 15671270 | GSE1393B_DOC | ||
| GSE1405 | LPS-induced and E. coli-induced gene expression in wildtype and MyD88-/- mouse macrophages | 15367722 | GSE1405_DOC | ||
| GSE1438 | Differential Gene Expression due to direct effects of IL-13 on Airway Epithelial Cells | 16083784 | GSE1438_DOC | ||
| GSE1467 | PancChp-HSLKO and WT | GSE1467_DOC | |||
| GSE1498 | Mammary carcinomas in c-Myc transgenic mice | GSE1498_DOC | |||
| GSE1506 | A404 Smooth Muscle Cell Differentiation | 15340120 | GSE1506_DOC | ||
| GSE1533 | In vivo selection of diverging tumor phenotypes | GSE1533_DOC | |||
| GSE1560 | Aortas of mice on high fat diet | 15550693 | GSE1560_DOC | ||
| GSE1564 | Electrical pacing of mouse muscle | GSE1564_DOC | |||
| GSE1574 | Time-course of mdx and wild type mice | GSE1574_DOC | |||
| GSE1580 | Analysis of murine epididymal adipose tissue | 15888570 | GSE1580_DOC | ||
| GSE1596 | Retinoic acid-induced neuroblastoma cells | GSE1596_DOC | |||
| GSE1597 | Differentiated vs undifferentiated neural stem cells | GSE1597_DOC | |||
| GSE1598 | Embryonic E14.5 telencephalon vs adult forebrain | 16107646 | GSE1598_DOC | ||
| GSE1636 | A multigene analysis of the effects of L-arginine treatment in the hindlimb and diaphragm muscles of mdx mice. | GSE1636_DOC | |||
| GSE1701 | Mouse Expression Database | GSE1701_DOC | |||
| GSE1742 | TGFbeta signalling in fibroblasts. | 15769904 | GSE1742_DOC | ||
| GSE1826 | Dexamethasone treatment of gut cells | 15826934 | GSE1826_DOC | ||
| GSE1840 | Identification of central nervous system genes involved in the host response to the scrapie agent. | 15483264 | GSE1840_DOC | ||
| GSE1863 | Dual Ligand Effects | GSE1863_DOC | |||
| GSE1897 | Mouse Hepatocellular Carcinoma Study | 15565109 | GSE1897_DOC | ||
| GSE1954 | CX43 heterozygous, Cx43 null and Cx32 null vs wildtype neonatal mouse brain | GSE1954_DOC | |||
| GSE1961 | Connexin43 null vs wildtype neonatal mouse HEART | 15585606 | GSE1961_DOC | ||
| GSE2001 | Skeletal Muscle Response | 16081620 | GSE2001_DOC | ||
| GSE2008 | Expression profiling of liver tissue from C57BL6 x DBA strain | 12646919 | GSE2008_DOC | ||
| GSE2050 | Major Patterns of B Cell Gene Expression Changes in Response to Short-Term Stimulation with 33 Single Ligands | 15585835 | GSE2050_DOC | ||
| GSE2083 | Microarray analysis of the fiber cell maturation in the lens | GSE2083_DOC | |||
| GSE2090 | Endothelial cells and exposure to enviromental tobacco | 15728332 | GSE2090_DOC | ||
| GSE2098 | A distinct and unique M2 transcriptional program expressed by tumor-associated macrophages | 16269622 | GSE2098_DOC | ||
| GSE2112 | Mouse Models for Muscular Dystrophy | 16306063 | GSE2112_DOC | ||
| GSE2464 | Spleen vs Neurokinin B (NEB) Treated B cell | GSE2464_DOC | |||
| GSE3165B | Identification of conserved gene expression features across human and murine mammary tumors murine mammary tumors | GSE3165B_DOC | |||
| GSE370 | Spleen vs 2-Methyl-thio-ATP Treated B cell | GSE370_DOC | |||
| GSE371 | Spleen vs Anti-IgM Treated B cell | GSE371_DOC | |||
| GSE372 | Spleen vs BAFF Treated B cell | GSE372_DOC | |||
| GSE373 | Spleen vs BLC Treated B cell | GSE373_DOC | |||
| GSE374 | Spleen vs Bombesin Treated B cell | GSE374_DOC | |||
| GSE375 | Spleen vs CD27 Treated B cell | GSE375_DOC | |||
| GSE376 | Spleen vs CD40 Treated B cell | GSE376_DOC | |||
| GSE377 | Spleen vs CGS Treated B cell | GSE377_DOC | |||
| GSE378 | Spleen vs CpG-oligodeoxynucleotide Treated B cell | GSE378_DOC | |||
| GSE379 | Spleen vs Dimaprit Treated B cell | GSE379_DOC | |||
| GSE380 | Spleen vs ELC Treated B cell | GSE380_DOC | |||
| GSE381 | Spleen vs fMLP Treated B cell | GSE381_DOC | |||
| GSE382 | Spleen vs GHRH Treated B cell | GSE382_DOC | |||
| GSE383 | Spleen vs IFN beta Treated B cell | GSE383_DOC | |||
| GSE384 | Spleen vs IFN gamma Treated B cell | GSE384_DOC | |||
| GSE385 | Spleen vs Insulin-like growth factor 1 gamma Treated B cell | GSE385_DOC | |||
| GSE386 | Spleen vs IL4 Treated B cell | GSE386_DOC | |||
| GSE387 | Spleen vs IL10 Treated B cell | GSE387_DOC | |||
| GSE388 | Spleen vs Lysophosphatidic Acid Treated B cell | GSE388_DOC | |||
| GSE389 | Spleen vs Lipopolysaccharide (LPS) Treated B cell | GSE389_DOC | |||
| GSE390 | Spleen vs Leukotriene B4 (LTB4) Treated B cell | GSE390_DOC | |||
| GSE391 | Spleen vs MIP3-alpha Treated B cell | GSE391_DOC | |||
| GSE392 | Spleen vs NGF (Nerve Growth Factor) Treated B cell | GSE392_DOC | |||
| GSE393 | Spleen vs Neuropeptide Y Treated B cell | GSE393_DOC | |||
| GSE394 | Spleen vs Platelet activating factor Treated B cell | GSE394_DOC | |||
| GSE395 | Spleen vs Prostaglandin E2 Treated B cell | GSE395_DOC | |||
| GSE396 | Spleen vs Sphingosine-1-phosphate Treated B cell | GSE396_DOC | |||
| GSE397 | Spleen vs SDF1 alpha (Stromal cell derived factor-1) Treated B cell | GSE397_DOC | |||
| GSE398 | Spleen vs SLC (Secondary lymphoid-organ chemokine) Treated B cell | GSE398_DOC | |||
| GSE399 | Spleen vs Terbutaline Treated B cell | GSE399_DOC | |||
| GSE400 | Spleen vs TGF-beta (transforming growth factor-beta) Treated B cell | GSE400_DOC | |||
| GSE401 | Spleen vs Tumor necrosis factor-alpha Treated B cell | GSE401_DOC | |||
| GSE402 | Spleen vs Untreated, cultured B cell | GSE402_DOC |